The QualityStocks Daily Stock List
- NexTech AR Solutions Corp. (NEXCF)
- Virpax Pharmaceuticals (VRPX)
- Nutex Health (NUTX)
- Corvus Pharmaceuticals (CRVS)
- Acelyrin Inc. (SLRN)
- Aurora Cannabis Inc. (ACB)
- Mind Medicine Inc. (MNMD)
- Lucid Group Inc. (LCID)
- Calidi Biotherapeutics (CLDI)
- Meta Platforms (META)
- Momo Inc. (MOMO)
- Bluejay Diagnostics Inc. (BJDX)
NexTech AR Solutions Corp. (NEXCF)
QualityStocks, SeriousTraders, Stocks to Buy Now, NetworkNewsWire, SmallCapRelations, InvestorBrandNetwork, MissionIR, Tip.us, TradersPro, MarketClub Analysis, StocksToBuyNow, CFN Media Group, Kiplinger Today, InvestorPlace, StockEarnings, Trades Of The Day and MarketBeat reported earlier on NexTech AR Solutions Corp. (NEXCF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
NexTech AR Solutions Corp. is one of the leaders in the fast growing AR (Augmented Reality) industry. The Company represents a first-mover opportunity in the augmented reality space with the creation of a transformational, patent-pending AR/AI eCommerce platform. NexTech is pursuing four multi-billion dollar verticals in AR. These are ARitize™ For eCommerce; ARitize™ University; ARitize™ Hollywood Studios, and ARitize™ 3D-AR-360 Advertising Platform. NexTech AR Solutions lists on the OTCQB.
Concerning ARitize™ For eCommerce, the Company launched its technologically advanced webAR for eCommerce early in 2019. NexTech has the first ‘full funnel’ end-to-end eCommerce solution for the AR industry including its 3D product capture, 3D ads for Facebook and Google, ‘Try it On’ technology for online apparel, 3D and 360-degree product views, and ‘one click buy’.
Regarding ARitize™ Hollywood Studios, it has created a proprietary entertainment venue for which it is producing immersive content using augmented reality as the primary display platform. ARitize™ University launched in June of 2019. The app-based solution enables companies and educational establishments to leverage all of their existing 2D assets - YouTube videos, PDF documents, PowerPoint decks, images, and more - and then overlay immersive 3D-AR experiences on top of that content for an interactive training experience that increases productivity.
NexTech AR Solutions has launched its ground-breaking CaptureAR technology, which will add to the revenue-generating power of the Company’s ARitize AR e-commerce solution and AR, 3D 360 advertising platform. CaptureAR simplifies 3D AR creation through capturing 3D AR products from 4K video that one can film with their cell phone’s camera. CaptureAR will now be included in NexTech’s ARitize augmented reality e-commerce solution.
NexTech AR Solutions Corp. (NEXCF), closed Tuesday's trading session at $0.1089, up 106.4455%, on 1,317,890 volume. The average volume for the last 3 months is 5.199M and the stock's 52-week low/high is $0.0451/$0.4534.
Virpax Pharmaceuticals (VRPX)
QualityStocks, MarketClub Analysis, The Online Investor, Schaeffer's and 360 Wall Street reported earlier on Virpax Pharmaceuticals (VRPX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Virpax Pharmaceuticals Inc. (NASDAQ: VRPX) is a preclinical stage biopharmaceutical firm that is engaged in the development and manufacture of non-addictive and non-opioid pharmaceutical products.
The firm has its headquarters in Berwyn, Pennsylvania and was incorporated in 2017 on May 12th by Anthony P. Mack. It operates as part of the pharmaceutical and medicine manufacturing industry, under the healthcare sector, in the biotech and pharma sub-industry. The firm serves consumers in the U.S.
The company manufactures its pharmaceuticals products through the use of drug delivery systems for pain management. It has global rights to an intranasal NCE (New Chemical Entity) that delivers encephalin to the brain for the treatment of PTSD and the management of cancer pain as well as chronic pain, using its Molecular Envelope Technology.
The enterprise’s product pipeline is made up of an encephalin intranasal spray for chronic and acute pin dubbed Envelta (NES100); a formulation indicated for chronic osteoarthritis affecting the knee, known as OSF200; a bupivacaine liposomal gel indicated for the management of post-op pain dubbed LBL100 (Probudur) and a metered-dose diclofenac spray film developed to manage acute musculoskeletal pain, known as Epoladerm. In addition to this, the enterprise is involved in the development of a masking spray that decreases or prevents the intensity or the risk of viral infections like the coronavirus in people, known as MMS019; and a formulation to manage PTSD, dubbed PES200.
The company recently announced that it would be submitting an Investigational New Drug application for its Envelta formulation for chronic pain. The approval of the application by the FDA will allow human trials to begin, bringing the firm one step closer to commercialization, if the treatment proves itself to be efficacious. The treatment’s success will not only be beneficial to patients but also bring in more investors into the firm, which will be good for the company’s growth.
Virpax Pharmaceuticals (VRPX), closed Tuesday's trading session at $1.51, up 41.1215%, on 12,193,909 volume. The average volume for the last 3 months is 30,042 and the stock's 52-week low/high is $0.4603/$10.00.
Nutex Health (NUTX)
QualityStocks, The Online Investor, MarketBeat, Prism MarketView, InsiderTrades and 360wallstreet reported earlier on Nutex Health (NUTX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Nutex Health Inc. (NASDAQ: NUTX) is a technology-enabled healthcare services firm that is engaged in the provision of healthcare services.
The firm has its headquarters in Houston, Texas and was incorporated in 2011. It operates as part of the health information services industry, under the healthcare sector. The firm serves consumers around the globe, with a primary focus on those in the United States.
The enterprise operates through the Population health management division and the Hospital division. The Hospital division is involved in operating and owning about 21 facilities which are located in 8 different states. This division is also involved in the operation and implementation of various health care models, including specialty hospitals, micro-hospitals and hospital outpatient departments. On the other hand, the Population health management segment is involved in the operation and owning of provider networks like IPAs (Independent Physician Associations). This division’s cloud-based proprietary technology platform also aggregates data across a range of information systems, sources and settings to create a holistic view of each provider and patients, while also facilitating care delivery. The enterprise’s Management Services Organizations offer administrative, management, and other support services to its affiliated physician groups and hospitals.
The company recently provided an update on its growth strategy, which showed that it had already launched two new micro-hospitals and was planning to increase the number of its facilities to 12. Its CEO noted that with their competitive advantages in the marketplace, the company was well positioned for strong growth and creating value for its shareholders.
Nutex Health (NUTX), closed Tuesday's trading session at $7.25, up 21.8487%, on 88,385 volume. The average volume for the last 3 months is 223,457 and the stock's 52-week low/high is $4.16/$68.07.
Corvus Pharmaceuticals (CRVS)
MarketBeat, MarketClub Analysis, StreetInsider, StockMarketWatch, Schaeffer's, QualityStocks, Zacks, BUYINS.NET, TopPennyStockMovers, TraderPower, The Street, PoliticsAndMyPortfolio, Penny Stock, TradersPro, Trades Of The Day and InsiderTrades reported earlier on Corvus Pharmaceuticals (CRVS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Corvus Pharmaceuticals Inc. (NASDAQ: CRVS) (FRA: C17) is a clinical stage biopharmaceutical firm that is focused on developing and commercializing immune-oncology therapies.
The firm has its headquarters in Burlingame, California and was incorporated in 2014, on January 27th by Joseph J. Buggy, Peter A. Thompson and Richard A. Miller. It operates as part of the pharmaceutical and medicine manufacturing industry, under the health care sector.
The company is party to a strategic collaboration with Angel Pharmaceuticals Ltd, which entails developing its pipeline of investigational medicines. The company serves consumers in the United States.
The enterprise’s product pipeline comprises of an oral small molecule A2A receptor antagonist dubbed CPI-444, which is undergoing a phase 2 clinical trial for adenosine; a covalent ITK inhibitor known as CPI-818, which is in a phase 1 clinical trial evaluating its effectiveness in treating individuals with malignant T-cell lymphomas; and an anti-CD73 monoclonal antibody dubbed CPI-006, which is undergoing a phase 3 trial for coronavirus as well as a phase 1 trial that activates different immune cells and inhibits adenosine production. The enterprise’s pre-clinical stage products include an adenosine A2B receptor antagonist dubbed CPI-935, which is indicated for fibrosis prevention; and an antibody known as CPI-182, which has been designed to block myeloid derived suppressor cells as well as neutrophil migration and function.
An Investigational New Drug application submitted by the company’s partner Angel Pharmaceuticals for their CPI-818 formulation has been accepted by the China National Medical Products Administration Center for Drug Evaluation. The success and approval of the formulation for use in treating relapsed/refractory T-cell lymphomas will benefit patients as well as bring in more revenues and investors into both companies.
Corvus Pharmaceuticals (CRVS), closed Tuesday's trading session at $2.33, up 16.5%, on 331,969 volume. The average volume for the last 3 months is 975,745 and the stock's 52-week low/high is $1.05/$2.86.
Acelyrin Inc. (SLRN)
MarketBeat, Schaeffer's, InsiderTrades and FreeRealTime reported earlier on Acelyrin Inc. (SLRN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Acelyrin Inc. (NASDAQ: SLRN) is a clinical biopharma firm focused on the identification, acquisition, and acceleration of the development and commercialization of transformative medicines.
The firm has its headquarters in Agoura Hills, California and was incorporated in 2020, on July 27th by Shao-Lee Lin. It operates as part of the biotechnology industry, under the healthcare sector. The firm serves patients primarily in the United States.
The enterprise is focused on offering patients new and life-changing treatment options. Its lead product candidate is izokibep, a small protein therapeutic designed to inhibit IL-17A with high potency, which is in Phase 3 clinical trials for use in the treatment of Hidradenitis Suppurativa, Psoriatic Arthritis, and uveitis. This formulation’s effectiveness is also being evaluated in a Phase 2 clinical trial targeting its use in treating Axial Spondyloarthritis. The enterprise is also developing lonigutamab, a subcutaneously delivered monoclonal antibody targeting IGF-1R being investigated in Phase 1 clinical trials that are testing its effectiveness in the treatment of thyroid eye disease. In addition to this, the enterprise develops SLRN-517, a fully human IgG1 monoclonal antibody targeting c-KIT, which is in preclinical stage for use in the treatment of chronic urticaria.
The company recently provided an update on its operations, with its CEO noting that their top priority was executing their strategy to accelerate the development and delivery of transformative medicines for patients. The future success of its formulations will not only benefit patients with various indications and encourage additional investments into the company, but also bolster its overall growth.
Acelyrin Inc. (SLRN), closed Tuesday's trading session at $7.06, up 15.1713%, on 3,517,450 volume. The average volume for the last 3 months is 3.668M and the stock's 52-week low/high is $3.67/$29.88.
Aurora Cannabis Inc. (ACB)
InvestorPlace, Schaeffer's, StocksEarning, MarketClub Analysis, MarketBeat, The Street, QualityStocks, StockEarnings, Trades Of The Day, Daily Trade Alert, StreetInsider, The Online Investor, Wealth Insider Alert, Market Intelligence Center Alert, Kiplinger Today, StockMarketWatch, CFN Media Group, Investopedia, Stock Up Featured, Profit Trends, CannabisNewsWire, BUYINS.NET, Jim Cramer, BlackSwanAlert, The Rich Investor, StreetAuthority Daily, Early Bird, Cannabis Financial Network News, Inside Trading, CNBC Breaking News, Daily Profit, Investors Alley, Investors Underground, Market Intelligence Center, Outsider Club, Zacks, Technology Profits Daily, The Wealth Report, TheTradingReport, Top Pros' Top Picks, Tradespoon, Wall Street Window and Money and Markets reported earlier on Aurora Cannabis Inc. (ACB), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
The marijuana industry has been significantly hindered by Section 280E of the IRS Code, which prevents businesses dealing with substances listed in Schedules 1 and 2 of the Controlled Substances Act (CSA) from deducting regular business expenses.
Although Section 280E affects federal deductions, the regulations are not governed by federal laws in half of the markets where marijuana businesses are licensed to sell the drug for recreational or medical purposes. This implies that when cannabis businesses submit their state taxes, they are not subject to Section 280E.
This provision has stunted the growth of legal cannabis businesses across the country. However, the sector is about to undergo a major financial shift due to the Biden administration’s proposal to reclassify the drug from Schedule 1 to 3.
Cannabis enterprises are subject to significant limitations on their income-tax obligations and tax filings under Schedule 1. They must also consider whether the states in which they conduct business adhere to federal tax rules.
Section 280E prevents companies from claiming a wide range of administrative, selling and general expenses that are typical for other businesses, including the following:
- Rent: Leasing space, a common deductible expense in other industries, cannot be deducted in the marijuana sector.
- Salaries and wages: Paying employees, from executives to budtenders, does not provide any tax relief.
- Utility costs: Essential utilities such as water and electricity cannot reduce the tax burden.
- Maintenance and repairs: Keeping facilities in good condition is a nondeductible expense, limiting reinvestment and improvements.
- Advertising and marketing: Promoting and building a brand drains funds without the benefit of tax write-offs.
- Health insurance: Providing medical coverage for employees is an unrecognized expense, affecting workforce stability.
- Amortization and depreciation: The gradual loss of asset value over time is not acknowledged by federal tax rules for nonplant-touching assets.
What could change if cannabis businesses were freed from the constraints of Section 280E? It would result in a scenario where the industry is no longer categorized alongside substances such as LSD and heroin but rather with everyday prescription medications.
For starters, cannabis businesses could claim deductions for typical expenses such as salaries, rent, utility bills, and advertising and marketing costs. Money saved from 280E could be reinvested into the enterprise, spurring growth, job creation, research and development.
Further, cost savings could be passed on to consumers, making medical marijuana more affordable and accessible. Additionally, with reduced stigma, obtaining loans, credit lines and banking services could become easier. Relief could also lead to competitive pricing for patients and consumers, reducing the appeal of the black market.
The potential for these changes has the industry excited and speculative. Will these possible deductions create a thriving economic environment for marijuana businesses, or will financial parity with other industries remain elusive?
One thing is certain: rescheduling cannabis and making Section 280E irrelevant for marijuana entities could unleash a flood of prosperity and turn a once-restricted sector into a major player in the financial world.
The question: when will the industry be able to reach its full potential financially? Marijuana companies such as Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) can only wait for the final rule to be published so that they ascertain how the change in policy will impact their tax obligations.
Aurora Cannabis Inc. (ACB), closed Tuesday's trading session at $6.21, up 1.9704%, on 1,736,290 volume. The average volume for the last 3 months is 1.432M and the stock's 52-week low/high is $2.84/$11.50.
Mind Medicine Inc. (MNMD)
QualityStocks, InvestorPlace, Schaeffer's, PsychedelicNewsWire, MarketBeat, TradersPro, The Wealth Report, The Street, The Stock Dork, MarketClub Analysis, Daily Trade Alert, Wealth Daily and Trades Of The Day reported earlier on Mind Medicine Inc. (MNMD), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Cluster headaches are headaches characterized by severe pain that often occurs on a side of the head or behind one eye. These headaches may last anywhere between 15 minutes to 3 hours and usually strike suddenly, often recurring more than once a day.
The pain experienced by patients is often intense and is sometimes accompanied by other symptoms such as restlessness, nasal congestion and redness in the eye.
Preliminary studies and anecdotal reports suggest that psilocybin may provide relief for this headache type. However, until now there wasn’t enough scientific evidence to back these claims.
New research has determined that psilocybin can help reduce cluster headache frequency. The study was carried out by researchers at Yale School of Medicine, led by assistant professor of neurology Emmanuelle A.D. Schindler.
The research team began by recruiting 16 adults aged between 21 and 65 years of age who got cluster headaches but had no other serious psychiatric or medical conditions. Each participant was randomly assigned to receive either a placebo or three psilocybin doses given at intervals of about five days. The psychedelic was administered in a controlled setting, with both the researchers and participants blinded to the dose administered.
In addition, each participant was required to keep a headache diary where they recorded the duration, intensity and frequency of their headaches.
The researchers discovered that the frequency of cluster headaches was substantially reduced by psilocybin, noting that participants who had received the psychedelic dose experienced an almost 50% drop in the number of headaches they experienced weekly.
On average, the researchers observed that these headaches dropped to 9.8 from 18.4, which demonstrates a significant improvement. This drop was observed in sufferers of both chronic and episodic cluster headaches. The researchers also observed that psilocybin’s therapeutic benefits appeared to be free of its hallucinogenic effects. This suggests that relief offered by the psychedelic may not be associated with its ability to alter an individual’s state of consciousness.
Additionally, the researchers observed considerable decreases in pain severity and the need for abortive drugs. In exact terms, they saw medication use drop by 37% and pain severity decrease by roughly 10%, which indicates an overall improvement in participants’ quality of life.
In their report, the researchers stated that while they observed no severe adverse events, other side effects such as cluster attacks, fatigue and nausea were observed during dosing sessions. While this study did have limitations, including a small sample size, the findings still highlight psilocybin’s potential as a treatment for cluster headaches.
The study was partly funded by Ceruvia Lifesciences and carried out under an Investigational new drug application with the U.S. Food and Drug Administration (FDA). Other researchers who took part in the study include Deepak C. D’Souza, R. Andrew Sewell, Nicholas V. Cozzi, Christopher H. Gottschalk, Brian P. Pittman, Yutong Zhu and L. Taylor Flynn.
Other companies, such as Mind Medicine Inc. (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ), are also studying psilocybin and other hallucinogens with a view to leveraging the medicinal potential of these substances. We could soon see these materials being used as mainstream treatments for ailments ranging from mental conditions to physiological issues.
Mind Medicine Inc. (MNMD), closed Tuesday's trading session at $8.49, up 8.5678%, on 1,591,622 volume. The average volume for the last 3 months is 28.209M and the stock's 52-week low/high is $2.41/$12.22.
Lucid Group Inc. (LCID)
Green Car Stocks, InvestorPlace, Schaeffer's, StockEarnings, QualityStocks, The Street, Early Bird, MarketClub Analysis, MarketBeat, GreenCarStocks, StocksEarning, Investopedia, INO Market Report, Daily Trade Alert, Trades Of The Day, Kiplinger Today, Money Wealth Matters, The Online Investor, BillionDollarClub, Louis Navellier, The Wealth Report, Zacks, Premium Stock Alerts, DividendStocks, The Night Owl, FreeRealTime, Cabot Wealth, Wealth Whisperer, Green Energy Stocks, Top Pros’ Top Picks, InvestorsUnderground, AllPennyStocks, The Stock Dork, Smartmoneytrading and InsiderTrades reported earlier on Lucid Group Inc. (LCID), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Lucid Group (NASDAQ: LCID), maker of the world's most-advanced electric vehicles, is reporting updates for its 2025 model year. According to the announcement, the updates “further raise the bar, enabling a landmark five miles per kilowatt hour of energy and record 146 MPGe EPA rating for the Air Pure.” The company also noted that the heat pump, which was initially featured on the Lucid Sapphire, will be standard across the lineup, resulting in improved real-world range; LCID models will also feature a powerful new infotainment processor designed to provide improved user experience. With these updates, the 2025 Lucid Air Pure will be the most efficient and thus most sustainable vehicle made, the company noted. “The advancements introduced across the Lucid Air lineup for 2025 further cement our leadership position,” said Lucid Group CEO and CTO Peter Rawlinson in the press release. “Lucid Air is the very embodiment of our relentless approach to optimization, enabling Air Pure to use less electrical energy than any other vehicle for any journey taken, A to B.”
To view the full press release, visit https://ibn.fm/CVCu0
About Lucid Group Inc.
Lucid is a Silicon Valley-based technology company focused on creating the most advanced EVs in the world. Its flagship vehicle, Lucid Air, delivers best-in-class performance and efficiency starting at $69,900*. Lucid is preparing its state-of-the-art, vertically integrated factory in Arizona to begin production of the Lucid Gravity SUV. The company's goal is to accelerate humanity's transition to sustainable transportation and energy through the creation of the most advanced EVs. For more information about the company, visit www.LucidMotors.com.
Lucid Group Inc. (LCID), closed Tuesday's trading session at $3.97, up 9.9723%, on 60,714,828 volume. The average volume for the last 3 months is 213,481 and the stock's 52-week low/high is $2.29/$7.75.
Calidi Biotherapeutics (CLDI)
MarketBeat, QualityStocks and Premium Stock Alerts reported earlier on Calidi Biotherapeutics (CLDI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Calidi Biotherapeutics (NYSE American: CLDI), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, has appointed a new member to its medical advisory board. According to the announcement, Mark Gilbert, MD, will be joining the board, bringing board membership to eight. A scientist emeritus at the National Institutes of Health (“NIH”), Gilbert served as chief of the neurooncology branch at NIH for a decade. During that time, Gilbert facilitated a team of laboratory and clinical investigators involved in groundbreaking research that advanced science in the brain tumor field. In addition to his experience at NIH, Gilbert practiced under world-renowned oncologist Dr. Alfred Yung, who is also a member of Calidi’s medical advisory board, MD Anderson in Houston; he also worked at UPMC in Pittsburgh, Emory University in Atlanta and Johns Hopkins in Baltimore. “We are honored that Dr. Gilbert has recognized the revolutionary science at Calidi Biotherapeutics in both tumoral and glioblastoma cancer treatment,” saidCalidi Biotherapeutics CEO Allan Camaisa in the press release. “He joins other luminaries on our medical advisory board who also believe in our stem-cell based therapy’s potential to offer hope and better results for those with cancer. . . . Dr. Gilbert’s expertise and experience will aid in guiding us on developing innovative, multi-institutional studies, partnering with national centers of excellence and key components of the NCI and NIH through Cooperative Research Development Agreements (‘CRADAs’) and other submissions. This will enable us to do some groundbreaking research to help people.”
To view the full press release, visit https://ibn.fm/TJuTU
About Calidi Biotherapeutics
Calidi Biotherapeutics (NYSE American: CLDI) is a clinical-stage immuno-oncology company with proprietary technology designed to arm the immune system to fight cancer. Calidi’s novel stem cell-based platforms are utilizing potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in multiple oncology indications, including high-grade gliomas and solid tumors. Calidi’s clinical stage off-the-shelf, universal cell-based delivery platforms are designed to protect, amplify, and potentiate oncolytic viruses leading to enhanced efficacy and improved patient safety. Calidi’s preclinical off-the-shelf enveloped virotherapies are designed to target disseminated solid tumors. This dual approach can potentially treat, or even prevent, metastatic disease. For more information about the company, please visit www.CalidiBio.com.
Calidi Biotherapeutics (CLDI), closed Tuesday's trading session at $1.8799, up 7.4229%, on 914,545 volume. The average volume for the last 3 months is 15.047M and the stock's 52-week low/high is $1.414/$137.90.
Meta Platforms (META)
The Street, Zacks, InvestorPlace, Early Bird, Schaeffer's, Investopedia, MarketClub Analysis, MarketBeat, The Online Investor, Kiplinger Today, INO Market Report, Cabot Wealth, Louis Navellier, TipRanks, Top Pros' Top Picks, Money Wealth Matters, The Night Owl, The Daily Market Alert, DividendStocks, Trading Tips, TradersPro, QualityStocks, AllPennyStocks, Eagle Financial Publications, Daily Wealth, InsiderTrades, Investment House, The Wealth Report, Trading with Larry Benedict, InvestorIntel, FreeRealTime, CNBC Breaking News, Smartmoneytrading, Market Trends, TradeSmith Daily, Inside Trading, Investing Breakout, Investing Daily, TradingPub, Stansberry Research, Jon Markman’s Pivotal Point, Marketbeat.com, Contrarian Outlook, Rick Saddler, Smart Investing Society, Investors Underground, Trade Out Loud, bullseyeoptiontrading, The Stock Dork, 360 Wall Street, Empire Financial Daily, Earnings360, Chaikin Analytics, empirefinancialresearch, wyatt research newsletter, Financial Newsletter, Hit and Run Candle Sticks, iDigital Market, Investor News, Investor's Business Daily, 1 2 3 Trade Option, MarketMovingTrends, Mind Over Markets, OTC Stock Review, StockReport, The Investing Insider, Timothy Sykes, The SmartMoneyTrading, Tim Bohen and Trading Pub reported earlier on Meta Platforms (META), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
The United States government’s recent memorandum with major social media companies, including Meta Platforms (NASDAQ: META), X and Snap (NYSE: SNAP), marks a significant step in the fight against the distribution of synthetic drugs online. Snap, known for its Snapchat application, is at the forefront of this initiative, showcasing its commitment to corporate responsibility. This collaboration aims to leverage the extensive reach and influence of these platforms to address a critical public health concern.
Snap, alongside its peers Meta and X, plays a pivotal role in the digital ecosystem, with millions of users engaging on their platforms daily. The agreement to curb the distribution of synthetic drugs not only highlights their social responsibility but also sets a precedent for how tech companies can work alongside government bodies to tackle complex issues. For Snap, this move is particularly noteworthy as it could enhance its reputation among users and regulators, emphasizing its dedication to creating a safe online environment.
The memorandum’s focus on preventing the distribution of synthetic drugs through social media platforms is a testament to the evolving role of these companies in society. By taking a stand against such activities, Snap and its counterparts are acknowledging the impact they have on public health and safety. Although the specific commitments and strategies were not disclosed, the initiative itself is a clear indication of their willingness to be part of the solution.
For Snap, the implications of this agreement extend beyond the immediate goal of curbing drug distribution. It could potentially influence user trust, as users may feel more secure knowing that the platform is actively working to eliminate harmful content. Additionally, this proactive approach could foster a more positive relationship with regulatory bodies, which is crucial for navigating the complex legal landscape of social media.
In summary, the memorandum signed between the U.S. government and major social media companies, including Snap, represents a collaborative effort to address a significant public health issue. For Snap, this initiative not only underscores its commitment to corporate responsibility but also has the potential to positively impact its relationship with users and regulators. By participating in this agreement, Snap is demonstrating its role as a responsible actor in the digital age, committed to ensuring the safety and well-being of its community.
To view the company’s most recent earnings release, visit https://ibn.fm/Fc4Iq
About Snap Inc.
Snap Inc. is a technology company. We believe the camera presents the greatest opportunity to improve the way people live and communicate. We contribute to human progress by empowering people to express themselves, live in the moment, learn about the world, and have fun together. For more information, visit the company’s website at www.Snap.com.
Meta Platforms (META), closed Tuesday's trading session at $489.79, off by 1.2839%, on 14,075,833 volume. The average volume for the last 3 months is 1.679M and the stock's 52-week low/high is $274.38/$542.81.
Momo Inc. (MOMO)
StocksEarning, QualityStocks, MarketClub Analysis, InvestorPlace, StockEarnings, Schaeffer's, Marketbeat, Market Intelligence Center Alert, Zacks, The Street, Trades Of The Day, Kiplinger Today, Daily Trade Alert, StreetInsider, The Street Report, Marketbeat.com, BUYINS.NET, The Online Investor, FreeRealTime, INO.com Market Report, ChineseWire, Trading Concepts, Louis Navellier, TradersPro, Wealth Insider Alert, StreetAuthority Daily, TopStockAnalysts, Money Morning, Investopedia, DividendStocks, Daily Wealth, PennyDoctor, TipRanks, Greenbackers, StockMarketWatch, StocksImpossible, Street Insider, OTCBB Journal, Early Bird, First Penny Picks, ChartAdvisor, Barchart, CrashTrade, Investing Signal, InvestmentHouse, Jason Bond, AskSlapper, Orbit Stocks, Profit Confidential, Promotion Stock Secrets, Short Term Wealth, Terry's Tips, The Best Newsletters, The Stock Dork and One Hot Stock reported earlier on Momo Inc. (MOMO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
The integration of dating apps such as Tinder and Bumble into relationships and the dating world may be contributing to rising rates of burnout and exhaustion. Dating apps were first introduced as a tool to make meeting potential partners easier. They allowed people to interact with individuals outside of their usual circles and undoubtedly helped foster relationships between people who likely would never meet if they relied on recommendations from family and friends.
However, their proliferation and use are increasingly being tied to burnout among people looking for partners. While many people met their current partners on dating applications, just as many have had to contend with months or even years of endless swiping and liking of profiles followed by awkward conversations that ultimately lead nowhere. This has culminated in a phenomenon experts call “dating app burnout.” After an endless barrage of profiles and pointless conversations, many individuals are growing tired of using dating apps.
California-based freelance photographer and photo editor Marilyn Espitia is one of those. The 31-year-old began using such applications in college and ultimately found her former partner and coparent on OkCupid. However, Espitia has been single for three years and has been primarily using Hinge to meet a partner, with occasional breaks from the dating platform when “it becomes too much.” The self-proclaimed “hopeless romantic” says the dating app can become overwhelming, a sentiment supported by licensed clinical psychologist Yasmine Saad.
The psychologist notes that an estimated three out of four people who visit her use dating apps and 80%–90% of them have mentioned burn out and feeling fatigued from using the apps. This is partly due to the fact that dating app users can never be sure their efforts will be successful, whether they are looking for a long-term partner or casual relationship. Saad, who is also the founder and CEO of New York-based Madison Park Psychological, says the process can be quite difficult as users tend to invest a lot and receive little in return.
According to Saad, dating app use can lead to issues with self-esteem and feelings of hopelessness. According to Boston University assistant professor of media science Kathryn Coduto, dating app burnout may have started as soon as tech companies introduced dating apps. Coduto has spent nearly a decade researching online dating and reports that burnout was also common in presmartphone platforms such as Match.com and eHarmony. Still, modern apps seem to have a greater impact because they are much more integrated into society.
The onus is now on companies in the online dating space, such as Momo Inc. (NASDAQ: MOMO), to leverage new technologies, including artificial intelligence (A) that can help users find matches faster while also addressing the safety risks that can make the online dating experience anxiety inducing for some people.
Momo Inc. (MOMO), closed Tuesday's trading session at $6.59, off by 0.3025719%, on 885,015 volume. The average volume for the last 3 months is 330,532 and the stock's 52-week low/high is $4.79/$11.12.
Bluejay Diagnostics Inc. (BJDX)
QualityStocks, StockEarnings, Trades Of The Day, The Online Investor, Premium Stock Alerts, MarketClub Analysis, MarketBeat, BioMedWire and 247 Market News reported earlier on Bluejay Diagnostics Inc. (BJDX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Bluejay (NASDAQ: BJDX), a medical technology company developing rapid diagnostics on its Symphony platform to improve patient outcomes in critical care settings, recently announced the closing of a firm commitment underwritten public offering. Expected gross proceeds to the company were approximately $8.75 million. The base offering consisted of 5,368,098 common units or prefunded units, each unit consisting of one share of the company’s common stock or one pre-funded warrant to purchase one share of common Stock, two Class C warrants each to purchase one share of common stock and one Class D warrant to purchase such number of shares of common stock as determined in the Class D warrant. In addition, the company granted Aegis Capital Corp. a 45-day option to purchase additional shares of common stock and/or common warrants, representing up to 15% of the number of securities sold in the offering, solely to cover over-allotments, if any.
To view the full press release, visit https://ibn.fm/IrpOu
About Bluejay Diagnostics Inc.
Bluejay is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay’s first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from ‘sample-to-result’ to help medical professionals make earlier and better triage/treatment decisions. More information is available at www.Bluejaydx.com.
Bluejay Diagnostics Inc. (BJDX), closed Tuesday's trading session at $0.5709, off by 0.3664922%, on 478,498 volume. The average volume for the last 3 months is 156,741 and the stock's 52-week low/high is $0.53/$111.8392.
The QualityStocks Company Corner
- Trillion Energy International Inc. (CSE: TCF) (OTCQB: TRLEF)
- Lexaria Bioscience Corp. (NASDAQ: LEXX)
- Emperor Metals Inc. (CSE: AUOZ) (FRA:9NH) (OTCQB: EMAUF)
- Software Effective Solutions Corp. (OTC: SFWJ)
- GEMXX Corp. (OTC: GEMZ)
- Horizon Fintex | Upstream
- Annovis Bio Inc. (NYSE: ANVS)
- Mullen Automotive Inc. (NASDAQ: MULN)
- CNS Pharmaceuticals Inc. (NASDAQ: CNSP)
- Correlate Energy Corp. (OTCQB: CIPI)
- Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF)
- Freight Technologies Inc. (NASDAQ: FRGT)
Trillion Energy International Inc. (CSE: TCF) (OTCQB: TRLEF)
The QualityStocks Daily Newsletter would like to spotlight Trillion Energy International Inc. (CSE: TCF) (OTCQB: TRLEF).
Trillion Energy (CSE: TCF) (OTCQB: TRLEF), a company focused on oil and natural gas production for Europe and Türkiye with natural gas assets in Türkiye, today provided an operational update for the SASB gas field well intervention program. "The fantastic response of South Akcakoca-2 once the water was lift off the perforations indicates that the reservoirs will produce the gas they contain once the water loading is removed," said Arthur Halleran, CEO of Trillion. "The wells are going to be perforated and monitored during clean up to evaluate the reservoirs response. The next phase of this project is to install the smaller production tubing (2 3/8") to allow the wells to produce for a few years before water loading occurs again."
To view the full press release, visit https://ibn.fm/IWJu0
Trillion Energy International Inc. (CSE: TCF) (OTCQB: TRLEF), along with its consolidated subsidiaries, is a Canadian oil and gas exploration and production company with operations primarily focused in the Republic of Türkiye.
Headquartered in Canada, the company owns 49% of the SASB natural gas field, which is producing critical domestic supply of natural gas during Europe’s ongoing energy shortages. It also holds a 19.6% (except three wells with 9.8%) ownership interest in the Cendere Oil Field and has a farm-in agreement to earn 50% interest in three oil exploration blocks in southeast Türkiye called Cudi-Gabar.
Trillion Energy utilizes state-of-the-art technology and ingenious practices to produce and distribute oil and natural gas while still maintaining a commitment to sustainable and responsible operations. Whether through the development of new projects or optimizing existing assets, the company continues to seek new and innovative ways to drive growth and value for its stakeholders.
Headquartered in Vancouver, British Columbia, Trillion Energy is led by seasoned professionals who collectively boast over a century of energy exploration and development experience.
Projects
SASB Gas Field
The SASB Gas Field is producing and delivering critical domestic supplies of natural gas as energy shortages grip Europe due to Russia’s invasion of Ukraine.
Located in the southwestern Black Sea, the SASB gas field consists of numerous conventional natural gas pools located in shallow water. The fields have produced over 43 billion cubic feet (BCF) since initial development in 2007 and continue to provide much needed energy to Türkiye and the EU. Total infrastructure to date, including production platforms, pipelines, initial wells and gas processing plant, cost in excess of $600 million.
Trillion Energy is redeveloping the field with a strategic planned program of approximately 17 wells which commenced in 2022. Phase B of the program, targeted for 2024/25, consists of the re-entry of five legacy wells to drill sidetrack development wells and one exploration stratigraphic well.
Cendere Oil Field
Trillion Energy’s Cendere oil field is a long-term, low decline, stable oil production field located in Türkiye. The company has a 19.6% interest in the field, except for three wells in which its interest is 9.8%.
Cash flow after operating costs from the field is $120,000 to $140,000 per month, with average current production netting the company 110-120 barrels of oil per day. Estimated remaining Cendere oil reserves total 1.5 million barrels (0.277 million barrels net Trillion Energy).
The gross value of Trillion Energy’s interest is estimated at $13.85 million (NPV10).
Cudi-Gabar
Trillion Energy’s 10-well oil exploration drilling program is occurring on three prospective oil blocks located in the prolific Cudi-Gabar oil province in southeast Türkiye. The total area of the three blocks is 374,325 acres.
Trillion Energy’s potential 50% working and revenue interest in the blocks is earned by paying 100% of the work program costs. The company will operate the exploration program.
During 2023/24, Trillion Energy will shoot 351 kilometers of 2D seismic (150 km already shot on the eastern block) and drill four wells. The remaining six wells will be paid 50% by Trillion and 50% by the company’s partner. The oil blocks are surrounded by more than 10 major oil discoveries, half of which are recent.
Market Opportunity
A January 2024 report by Emergen Research, a market research and consulting company, estimated the global natural gas market at $310.5 trillion in 2022 and projected the market will be worth $443.8 trillion by 2032, achieving a CAGR of 3.7% during the forecast period. Increasing global economic activity and rising electricity consumption are key factors driving revenue growth of the market, according to the report.
Trillion Energy reports strong demand for natural gas in Türkiye, which is the seventh-largest natural gas consuming country in the world. Türkiye currently imports 98% of the natural gas it consumes, with about 60% of those imports coming from Iran and Russia.
Management Team
Dr. Arthur Halleran is CEO and Director of Trillion Energy. He has a Ph.D. in Geology from the University of Calgary and 44 years of petroleum exploration and development experience. His international experience includes work in Canada, Colombia, Egypt, India, Guinea, Sierra Leone, Sudan, Suriname, Chile, Brazil, Bulgaria, Türkiye, Pakistan, Peru, Tunisia, Trinidad Tobago, Argentina, Ecuador and Guyana. Dr. Halleran has worked for Petro-Canada, Chevron, Rally Energy and United Hydrocarbon International Corp. In 2007, he founded Canacol Energy Ltd., now the largest natural gas producer in Colombia.
Al Thorsen is COO of Trillion Energy. He is responsible for production operations of the SASB gas field, as well as future drilling activities in Türkiye and abroad. Highlights of his career include Valeura Energy Inc. as operations manager in Türkiye; Journey Energy, leading a production team; Rio Alto Exploration as country manager and production manager; Zargon Oil and Gas as VP of Operations; Orleans Energy as VP of Operations; and Central Petroleum as COO. He holds a Bachelor of Science in Petroleum Engineering from Montana College of Mineral Science & Technology.
Trillion Energy International Inc. (OTCQB: TRLEF), closed Tuesday's trading session at $0.1115, up 16.6318%, on 163,811 volume. The average volume for the last 3 months is 205,486 and the stock's 52-week low/high is $0.0682/$1.4375.
Recent News
- Trillion Energy International Inc. (CSE: TCF) (OTCQB: TRLEF) - InvestorNewsBreaks - Trillion Energy International Inc. (CSE: TCF) (OTCQB: TRLEF) Issues Update on SASB Program
- InvestorNewsBreaks - Trillion Energy International Inc. (CSE: TCF) (OTCQB: TRLEF) (Frankfurt: Z62) Upsizes, Closes Nonbrokered Private Placement
- TRILLION ENERGY COMMENCES WORK PROGRAM AT SASB GAS FIELD
Lexaria Bioscience Corp. (NASDAQ: LEXX)
The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (NASDAQ: LEXX).
Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, is preparing for growth by executing a strategic growth plan. A key element of the plan includes expanding the company's management team to enable efficient handling of a greater workload of projects and initiatives. With that in mind, the company has named Nelson Cabatuan as consulting chief strategic financial advisor; Cabatuan is currently serving as Lexaria CFO. In his new role, Cabatuan will leverage his skills in corporate finance and strategic industry relationships to focus on strategic opportunities. In addition, Lexaria is working on other research and development projects in connection with GLP-1 molecules of interest and is closely evaluating its phase 1b hypertension study, which has received clearance from the U.S. Food and Drug Administration to proceed, to determine next steps. "Lexaria has certain initiatives underway that are increasing confidence in our medium-term and longer-term strategies," said Lexaria Bioscience CEO Chris Bunka in the press release. "As a result of the success we are experiencing and the continued success we are anticipating, we will be implementing a number of strategic steps in the weeks and months to come."
To view the full press release, visit https://ibn.fm/Hlbd0 Lexaria Bioscience Corp. (NASDAQ: LEXX) is a global innovator in drug delivery platforms. The company’s patented technology, DehydraTECH™, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting healthier oral ingestion methods and increasing the effectiveness of fat-soluble active molecules. DehydraTECH promotes fast-acting, less expensive and more effective oral drug delivery and has been thoroughly evaluated through in vivo, in vitro and human clinical testing. DehydraTECH is covered by 21 issued and more than 50 pending patents in over 40 countries around the world. Lexaria’s first patent was issued by the U.S. Patent and Trademark Office in October 2016 (US 9,474,725 B1), providing 20 years of patent protection expiring June 2034. Multiple patents have been awarded since then and are expected in the future. Lexaria has also collaborated with the National Research Council (NRC), the Canadian government’s premier research and technology organization. The company has been granted patent protection for specific delivery of nicotine, vitamins, NSAIDs, antiviral drugs, cannabinoids and more. Lexaria began developing DehydraTECH in 2014 and has since continued to strengthen and broaden the technology. The company has no plans to create or sell Lexaria-branded products containing controlled substances. Instead, Lexaria licenses its technology to other companies around the world to offer consumers the best possible performance across an array of ingestible product formats. The company’s technology is best thought of as an additional layer that providers of consumer supplements, prescription and non-prescription drugs, nicotine and CBD products can utilize to improve the effectiveness of their own existing or planned new offerings. Lexaria has licensed DehydraTECH to multiple companies, including a world-leading tobacco producer for the research and development of smokeless, oral-based nicotine products, and for use in industries that produce cannabinoid beverages, edibles and oral products. DehydraTECH is suitable for use with a wide range of product formats including pharmaceuticals, nutraceuticals, consumer packaged goods and over-the-counter capsules, pills, tablets and oral suspensions. DehydraTECH Technology Lexaria’s DehydraTECH is designed specifically for formulating and delivering lipophilic (fat-soluble) drugs and active ingredients. DehydraTECH increases their effectiveness and improves the way active pharmaceutical ingredients enter the bloodstream. The major benefits to a subject ingesting a DehydraTECH-enabled drug or consumer product can be summarized by the following: Lexaria has demonstrated in animal studies a propensity for DehydraTECH technology to elevate the quantity of drug delivered across the blood-brain barrier by as much as 1,900 percent, initiating additional new patent applications and opening possibilities for improved drug delivery. Since 2016, DehydraTECH has repeatedly demonstrated, with cannabinoids and nicotine, the ability to increase bio-absorption by up to five to 10 times, reduce time of onset from one to two hours to just minutes, and mask unwanted tastes. The technology is to be further evaluated for additional orally administered bioactive molecules, including antivirals, cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs) and nicotine. Market Outlook Lexaria’s ongoing research and development efforts are mainly focused on development of product candidates across several key segments: Management Team Chris Bunka is Chairman and CEO of Lexaria Bioscience Corp. He is a serial entrepreneur who has been involved in several private and public companies since the late 1980s. He has extensive experience in the capital markets, corporate governance, mergers and acquisitions, as well as corporate finance. He is named as an inventor on multiple patent innovations. John Docherty, M.Sc., is the President of Lexaria. He is a pharmacologist and toxicologist, and a specialist in the development of drug delivery technologies. He is the former president and COO of Helix BioPharma Corp. (TSX: HBP). He is named as an inventor on multiple issued and pending patents. Greg Downey is Lexaria’s CFO. He has more than 35 years of diverse financial experience in the mining, oil and gas, manufacturing, and construction industries, and in the public sector. He served for eight years as CFO for several public companies and has provided business advisory and financial accounting services to many large organizations. Gregg Smith is a strategic advisor to Lexaria. He is a founder and private investor with Evolution VC Partners. He is a member of the Sand Hill Angels and held previous investment banking roles with Cowen and Company and Bank of America Merrill Lynch. Dr. Philip Ainslie serves as a scientific and medical advisor to Lexaria. He is co-director for the Centre for Heart, Lung and Vascular Health, Canada. He is also Research Chair in Cerebrovascular Physiology and Professor at the School of Health and Exercise Sciences, Faculty of Health and Social Development at the University of British Columbia. Lexaria Bioscience Corp. (LEXX), closed Tuesday's trading session at $2.97, up 2.0619%, on 87,812 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $1.4375/$.
Recent News
Emperor Metals Inc. (CSE: AUOZ) (FRA:9NH) (OTCQB: EMAUF)
The QualityStocks Daily Newsletter would like to spotlight Emperor Metals Inc. (CSE: AUOZ) (FRA:9NH) (OTCQB: EMAUF).
Emperor Metals (CSE: AUOZ) (OTCQB: EMAUF) (FRA: 9NH), an advanced-stage, gold-exploration company focused on proving and developing the substantial resource potential of its flagship Duquesne West Gold Project, announced that it is exploring the eastern portion of the project. According to the announcement, that exploration includes a "conceptual open pit model toward the Nip Zone, focusing on untested potentially high-grade gold targets after completing 30% (2,500 meters) of the ongoing 8,000-meter drill program at the Duquesne West Gold Project." The company reported robust thickness of high-grade gold intercepts at the Nip Zone, making the area a top priority for exploration. Noting that the area has been "relatively unexplored," the company observed that the Nip Zone has "very encouraging historical gold intercepts that will likely be very valuable towards the expansion and development of this property." The announcement also stated that by concentrating drilling near surface mineralization within an ultimate conceptual open pit, the company could add ounces more rapidly and mine at a significantly lower grade compared to an underground mining situation. "Early visuals of our current drilling campaign have been intriguing, and we look forward to seeing the assay results," said Emporer Metals CEO John Florek in the press release. "We have a significant opportunity to expand this deposit eastward to potentially double the footprint of this deposit with no sign of an outer limit at this stage."
To view the full press release, visit https://ibn.fm/KyCLz
Emperor Metals Inc. (CSE: AUOZ) (FRA:9NH) (OTCQB: EMAUF) is an advanced stage gold exploration company focused on proving and developing the substantial resource potential of its flagship Duquesne West Gold Project located in the Tier 1 district of the Southern Abitibi Greenstone belt of Rouyn-Noranda, Quebec. The Project has a 2011 historical mineral resource estimate of 727,000 ounces of Au at 5.42 g/t and an average thickness of 5.71 m*.
In 2023, with the use of AI (Artificial Intelligence), Emperor Metals created the first ever 3D mineralized and geological model, which illuminated the potential to add significant ounces to this deposit. Using these models, Emperor’s had a very successful 2023 drilling campaign of 8,579 m. In addition to laterally extending high grade zones by intercepting grades of 15.8 g/t Au over 10.8 meters, Emperor encountered intercepts of lower grade bulk tonnage in the host rocks (1.69 g/t Au over 25 m). This led to envisioning a different strategy of exploration and the revelation that a conceptual open-pit potentially overlies this high-grade gold deposit. Historic core sampling began (2,500 m) for discovering overlooked lower grade gold in the host rock around the high-grade lenses. Lower grade bulk tonnage gold improves the open-pit economics by reducing stripping ratios and adding overlooked incremental ounces for open pit mining.
Emperor Metals is set to begin a fully funded Phase II 8,000 m drilling program in May 2024. The company also plans on assaying an additional 8,000 m of historic core within the open pit model. Emperor is working toward producing an updated NI 43-101 Mineral Resource Estimate by Q1 2025.
The company is led by a dynamic group of resource sector professionals who have a strong record of success in evaluating and advancing mining projects from exploration through to production, attracting capital and overcoming adversity to deliver exceptional shareholder value.
Project
Emperor Metals has an option to earn 100% ownership of the Duquesne West Gold Project, a mineral claim package comprising 38 claims covering approximately 1,389 ha (3,432 acres) in Quebec.
The Duquesne West Gold Property is located 32 kilometers northwest of the city of Rouyn-Noranda and 10 kilometers east of the town of Duparquet. The property lies within the historic Duparquet gold mining camp in the southern portion of the Abitibi Greenstone Belt in the Superior Province.
Emperor is targeting the potential multimillion-ounce resource in a combination of conceptual open pit and underground mining scenarios. A Phase I drill campaign and historical core sampling program was completed in 2023, which included resource confirmation and exploration drilling, focusing on delineating and growing the resource toward development.
The property hosts a historical inferred mineral resource estimate of 727,000 ounces of gold at a grade of 5.42 grams per ton (g/t) and average stope thickness of 5.71 m. The mineral resource estimate predates modern Canadian Institute of Mining guidelines, and a Qualified Person on behalf of Emperor Metals has not reviewed or verified the mineral resource estimate. Therefore, it is considered historical in nature and is reported solely to provide an indication of the magnitude of mineralization that could be present on the property. The gold system remains open for resource identification and expansion.
Reinterpretation of the existing geological model was created using artificial intelligence and machine learning. This AI model shows the opportunity for additional discovery of ounces by revealing gold trends unknown to previous workers and the potential to expand the resource along significant gold-endowed structural zones. Multiple scenarios exist to expand additional resources, which include:
- Underground High-Grade Gold
- Open Pit Bulk Tonnage Gold
- Underground Bulk Tonnage Gold
The Duquesne West-Ottoman property straddles the Porcupine-Destor gold localizing fault several kilometers east of the town of Duparquet. A number of previous drill campaigns have outlined an inferred resource of 4.17 million tons grading 5.42 g/t of gold (cut) or 6.36 g/t (uncut), as reported in the NI 43-101 report titled “Technical Report and Mineral Resource Estimate Update for the Duquesne-Ottoman Property, Quebec, Canada.”
Emperor Metals is funded for an 8,000-meter drilling program focusing primarily on adding ounces to the current resource within and lateral to the open pit model. An additional 8,000 m of historical core sampling and assaying is included in the budget to help build incremental ounces in the open-pit environment.
Market Opportunity
The World Gold Council, the industry association for the world’s gold producers, estimated in 2023 the physical financial gold market, which is made up of bars, coins, gold ETFs and central bank reserves, to be worth nearly $5 trillion.
The council reports that gold mine production adds approximately 3,500 tons of the precious metal to the world’s supply annually, equivalent to about 2% growth. This historical scarcity and relatively slow production of new supply, as compared to other commodities, is a primary reason gold has retained its value for millennia, according to the council.
In May 2024, the market price of gold was approximately $2,340 per ounce.
Management Team
John Florek, P.Geol., is President, CEO and Director of Emperor Metals. He has more than 35 years of technical and senior management experience with major and junior mining companies, including roles as founder, vice president and director. He has helped identify and develop significant asset value for mines and exploration projects from grass roots through development. He has worked for several major mineral producers, including BHP, Placer Dome, Barrick, Teck and Detour Gold/Kirkland Lake Gold/Agnico Eagle.
Sean Mager is CFO and Director of Emperor Metals. He has worked more than 30 years in the mining sector, including extensive experience in corporate development, stakeholder relations, regulatory, financial and operations.
Alex Horsley is Head of Corporate Development and Director of Emperor Metals. He has more than 20 years of experience in the mining sector and capital markets with a focus on finance, marketing, management, corporate development and communications. He is founder and former CEO of Emperor Metals. He has assisted in raising more than C$40 million for exploration and development mining companies.
*Power-Fardy and Breede, 2011. The Mineral Resource Estimate (MRE) constructed in 2011 is considered historical in nature as it was constructed prior to the most recent Canadian Institute of Mining and Metallurgy (CIM) standards (2014) and guidelines (2019) for mineral resources. In addition, the economic factors used to demonstrate reasonable prospects of eventual economic extraction for the MRE have changed since 2011. A qualified person has not done sufficient work to consider the MRE as current. Emperor is not treating the historical MRE as current. The reader is cautioned not to treat it, or any part of it, as a current MRE.
Emperor Metals Inc. (OTCQB: EMAUF), closed Tuesday's trading session at $0.091, up 3.4091%, on 167,600 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.0597/$0.14505.
Recent News
- Emperor Metals Inc. (CSE: AUOZ) (FRA:9NH) (OTCQB: EMAUF) - InvestorNewsBreaks - Emperor Metals Inc. (CSE: AUOZ) (OTCQB: EMAUF) (FRA: 9NH) Reports on Plans to Explore Eastern Extent at Duquesne West Gold Project
- MiningNewsBreaks - Emperor Metals Inc. (CSE: AUOZ) (OTCQB: EMAUF) (FRA: 9NH) Enhancing Asset Portfolio with Fully Funded Phase II Drilling Program
- Anticipated Imbalance in Gold Supply & Demand, Portends Market Boon for Emperor Metals Inc. (CSE: AUOZ) (OTCQB: EMAUF) (FRA: 9NH) Exploration Project
Software Effective Solutions Corp. (OTC: SFWJ)
The QualityStocks Daily Newsletter would like to spotlight Software Effective Solutions Corp. (OTC: SFWJ).
An overwhelming share of U.S. adults say marijuana should be legal for medical or recreational use, reports Pew Research Center
The U.S. attorney general has submitted official notice to begin the process of moving marijuana from a Schedule 1 to Schedule 3 drug under the Controlled Substances Act
MedCana is committed to building the technology, laboratories, growing facilities and scientific teams to provide premium pharmaceutical-grade cannabis extracts
With a significant majority of Americans supporting cannabis use and the U.S. government on the verge of changing the status of the substance under the Controlled Substances Act ("CSA"), Software Effective Solutions (d/b/a MedCana) (OTC: SFWJ) is positioning itself for marked growth and success in the coming months. The company's goal is to be the world's premier resource for pharmaceutical cannabis products.
Earlier this week, the National Institute of Standards and Technology (NIST) announced that it was selling reference material on hemp that would assist labs in correctly measuring components in products made from the cannabis plant. The reference material was made from commercially purchased dried hemp, which the researchers ground, sieved, blended and measured to a high degree of precision and accuracy. Each unit includes three packets with 1.5 grams of ground hemp. This material will also help agencies of law enforcement accurately differentiate between marijuana and hemp, given that both come from the cannabis plant. In addition, the reference material contains moisture content measurements. This is crucial because it assists laboratories in reporting levels of substances such as THC on a dry-weight basis. Furthermore, the material will also assist investigators conducting research on the health and effects of cannabis to measure dosages used for research accurately. This will, in turn, allow investigators to compare findings from different studies with little difficulty. The cannabis industry, including entities such as Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ), are likely to welcome these efforts being undertaken to foster some degree of standardization in the way testing labs assess the samples sent to them.
Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ) is a global infrastructure and holding company in the cannabis industry. MedCana currently has five companies focused on pharmaceutical cannabis production, as well a software company focused on managing processes for plant-to-patient operations. The recent acquisition of an irrigation and greenhouse technology company has rounded out MedCana’s portfolio of holdings.
MedCana’s focus is on developing clients and companies in Latin America, initially in Colombia, and partnerships with laboratories, research facilities and hospitals throughout the world. MedCana is building the technology, laboratories, growing facilities and scientific teams to provide premium pharmaceutical-grade cannabis extracts to the world.
MedCana’s goal is to be the world’s premier resource for pharmaceutical cannabis products. The company believes its advantage is its global view and reach. From initial cultivation to final product, MedCana aims to help partners produce pharmaceutical CBD and other extracts that will have no equal.
The company’s mission is to utilize its technology to partner with and develop companies that provide premium pharmaceutical-grade cannabis extracts with absolute integrity, sustainability and social responsibility. MedCana’s team of pharmaceutical scientists includes some of the most respected chemists in the world. They aim to ensure that the company’s customers and partners create premium cannabis extracts that meet the growing worldwide demand. MedCana’s software is designed to ensure traceability and quality from seed to finished product.
MedCana is headquartered in Austin, Texas, with offices in Colombia.
Production
MedCana announced in May 2023 the beginning of full-scale production of non-THC cannabis for export to Europe in response to high demand in that market. This expansion comes after the successful completion of full crop cycle testing and infrastructure development at production sites in Columbia.
The recent acquisition of the assets of Tokan Corp., a software company focused on creating an enterprise resource planning (ERP) platform for the cannabis industry, and Eko2O S.A.S., a greenhouse and irrigation engineering company, has positioned MedCana for explosive growth in the region.
As a MedCana subsidiary, Eko2O SA will increase the company’s revenue potential in Central and South America. The subsidiary specializes in the construction and distribution of greenhouses and sophisticated irrigation platforms. A positive outlook has resulted from the company’s expansion as it investigates new opportunities for greenhouse and irrigation system installations in Panama and Uruguay. These opportunities are expected to accelerate Eko2O’s development and strengthen its position as a top supplier of innovative agricultural solutions in cannabis and other sectors that are quickly moving to high technology agricultural production.
In addition, MedCana has started talks with the government in Argentina about possible incentives for beginning operations in that country as part of its ongoing worldwide development strategy. Support from the Argentinean government and the start of new operations there would greatly increase MedCana’s market share in Latin America and solidify the company’s position as the market leader in the cannabis industry.
Market Opportunity
According to a report by Grand View Research, a San Francisco-based market research and consulting company, the global cannabis extract market was valued at $3.5 billion in 2022 and is expected to expand at a CAGR of 20% from 2023 to 2030 to be worth more than $15 billion.
Growing demand for cannabis extracts, including oils and tinctures, and the increased legalization of marijuana for the treatment of different chronic ailments like arthritis, Alzheimer’s, anxiety and cancer are driving the expansion of the industry. The marijuana derivative industry is flourishing due to a greater understanding of its various medical benefits.
Management Team
Jose Gabriel Diaz is CEO of MedCana. He has successfully built, grown and sold multiple telecom companies. He was senior vice president of sales at IP Communications, a national high-speed data provider. He also founded Reallinx, a national data carrier later sold to GTT Communications. Additionally, he is currently president of the A.E.M. Business and Entrepreneurship Association in Austin, Texas.
Claudio Jiménez Cartagena, QF, Ph.D. is Chief Scientific Officer at MedCana. He joined MedCana after working with Sosteli Pharma as Technical Director and serving as a director consultant for the Corporation for Agricultural Industrial Development at the University of Antioquia in Colombia. Before that, he worked as the scientific director at the Institute of Food Science & Technology. He holds a bachelor’s degree in pharmaceutical chemistry, a master’s degree in basic biomedical sciences and a doctoral degree in Environmental Engineering from the University of Antioquia.
Julián Alberto Londoño Londoño, Ph.D., is Senior Vice President of Operations at MedCana. He previously served as general manager for the Corporation for Agricultural Industrial Development, and as Chief Scientific Officer at Sosteli Pharma in the Resource Management Department. He has developed multiple U.S. patents, and recently served as senior advisor to the Secretariat of Agriculture Development for the Government of Antioquia. He holds a doctorate in Chemical Sciences from the University of Antioquia.
Software Effective Solutions Corp. (OTC: SFWJ), closed Tuesday's trading session at $0.035, even for the day. The average volume for the last 3 months is and the stock's 52-week low/high is $0.000001/$0.09.
Recent News
- Software Effective Solutions Corp. (OTC: SFWJ) - New Hemp Reference Material from NIST to Ensure Accuracy in Cannabis Measurement
- Software Effective Solutions Corp. (SFWJ) Strengthening Cannabis Foothold as CSA Status Set to Change
- CannabisNewsBreaks - Software Effective Solutions Corp. (SFWJ) Ideally Positioned as DEA's Move to Reclassify Cannabis Signals New Era
GEMXX Corp. (OTC: GEMZ)
The QualityStocks Daily Newsletter would like to spotlight GEMXX Corp. (OTC: GEMZ) .
GEMXX recently announced the addition of Ali S. Abood to the board of its primary investment target, Latin Energy Partners ("LEP")
The company signed in early June a definitive agreement with LEP to drill four test wells in a highly promising geological formation in Latin America
GEMXX and LEP are joining forces to fully harness the potential of two target basins estimated to hold more than 1 billion barrels each of recoverable oil
The strategic addition of Mr. Abood to LEP's board aligns with its commitment to strengthening its investment portfolio and expanding its influence in the global energy sector
Mr. Abood brings a wealth of experience in international business, finance, and consultancy, having held senior directorships and advisory roles in multiple multinational corporations and done consultancy work for defense, engineering, and technology firms
GEMXX (OTC: GEMZ), a mine-to-market gold, gemstone, and jewelry producer with global reach, earlier this month signed a definitive agreement with Latin America Partners ("LEP"), an emerging leader and an independent E&P company involved in exploring significant hydrocarbon reserves in Latin America. The agreement kickstarted a collaboration to drill four test wells in a highly promising geological formation in Latin America, representing a significant milestone in the company's expansion into the energy sector (https://ibn.fm/u6FWY).
GEMXX Corp. (OTC: GEMZ) is a mine-to-market enterprise specializing in gold, gemstone, and jewelry production. With ownership of mining resources, production facilities, and operational assets, the company maintains control over every aspect of its production process, from gold mining and gemstone extraction to jewelry manufacturing and global distribution.
As a prominent player in the industry, GEMXX stands out as a leading producer of high-quality finished Ammolite jewelry. Notably, it holds the distinction of being the sole public company engaged in Ammolite mining worldwide. In addition to its Ammolite operations, the company is actively involved in gold mining and prides itself on its ability to design and manufacture exquisite jewelry pieces and exceptionally rare, natural fossil decor items for clientele around the globe.
One of GEMXX’s key advantages lies in mining its own gold reserves to be utilized in its jewelry production. This strategic approach provides the company with a cost-saving edge over other producers in the market.
Ammolite is similar to black opal and is a biogenic gem like amber and pearl. It is derived from the fossilized shells of ammonites, a group of extinct marine nautiluses.
GEMXX’s world class gemstone cutters and jewelry designers are continuously leading the Ammolite industry. Its team believes in the company’s philosophy, vision and goals, and works every day to continue to drive the Ammolite industry to the forefront of the gem world.
The company has offices in Las Vegas and Hong Kong.
Projects and Operations
GEMXX has formulated an ambitious growth plan that, while challenging, is deemed attainable. The company’s strategy revolves around bolstering its market share through several key initiatives. Firstly, GEMXX aims to strengthen its position in current markets by nurturing and expanding existing relationships with customers and partners.
Secondly, the company plans to venture into untapped markets strategically. By identifying and targeting new areas, GEMXX seeks to establish a presence in regions that present promising opportunities for growth.
Additionally, GEMXX envisions growth through acquisitions. By considering and integrating key services, distribution networks and retail outlets into its fold, the company aims to consolidate its market position and capitalize on synergies for enhanced success.
To cater to the rising demand for its products, GEMXX has placed a primary focus on increasing gemstone production. The company’s southern properties, situated in Alberta, Canada, hold valuable deposits of rough Ammolite gemstone. By tapping into these resources, GEMXX is poised to meet the demand for its exquisite gemstone products and further fuel its expansion plans.
GEMXX possesses significant mineral assets in the form of a Mineral Work Permit covering an 800-acre area and two Ammonite Shell Mineral agreements encompassing 217 acres within the same region. The company’s management effectively operated mines in close proximity to these properties. Moreover, core sampling, along with fossil outcroppings on the riverbanks, confirms a substantial Ammolite resource present in these designated areas.
Both the Mineral Work Permit and the Ammonite Shell Mineral agreements grant GEMXX unrestricted access to all Ammolite resources within their respective demarcations. Notably, the company is not obligated to pay any royalties to third parties, thereby enabling GEMXX to fully capitalize on the potential of these valuable resources.
Furthermore, there are no stringent regulatory conditions that GEMXX must fulfill to gain or retain access to the Ammolite deposits. This freedom of access allows the company to proceed with its mining and production operations unimpeded, providing an advantageous position for future growth and success.
In March 2023, GEMXX made a significant announcement, revealing its acquisition of a 50% ownership stake in Crazy Horse Mining Inc., a Canadian gold mining company with assets situated in the province of British Columbia. As part of this deal, Crazy Horse’s assets, which encompass a 100% interest in two gold projects, called Snow Creek and Rosella Creek, spread across a substantial area exceeding 700 acres, now become part of GEMXX’s portfolio.
Under the terms of this strategic partnership, GEMXX and Crazy Horse will jointly share the expenses related to mining operations on these projects. Additionally, the two companies will share the gold produced from these ventures, leading to a collaborative and mutually beneficial arrangement.
Initial tests conducted on the property, combined with gold already recovered this season, confirm all expectations for the claims and substantiate the company’s estimated extraction target of over 100,000 ounces of easily recoverable gold. To validate and provide a more comprehensive assessment of this estimate, an S-K 1300-compliant Resource Report is scheduled to be conducted during the summer of 2023.
By acquiring this stake in Crazy Horse Mining Inc., GEMXX has positioned itself for further growth in the gold mining sector and is poised to capitalize on cost of goods savings in its jewelry business.
Market Opportunity
Leading independent market research companies such as Data Monitor and GIA estimate the worldwide market for luxury or premium lifestyle products, which include gems and jewelry, at over $90 billion annually and growing. Ammolite sales around the world have seen unprecedented growth over the past 20 years. Worldwide retail sales are now estimated to be over $100 million.
Ammolite jewelry and fossils are featured aboard cruise ships and can be found in specialty shops in almost every cruise port in North America. Asian markets have grown since feng shui master Edward Li called Ammolite the most influential stone of the new millennium, referring to it as the “Seven Color Prosperity Stone.” Home shopping channels in Japan, Australia, France, Germany, the UK, Canada and the U.S. have all featured Ammolite jewelry.
Ammolite and ammonites can also be found on many ecommerce sales platforms, including Amazon, eBay and Etsy. Ammolite is sold around the world in tourist and traditional jewelry markets. The company has established customers in home shopping channels, cruise tourism, jewelry retailers, Asian feng shui markets, Asian retail markets and ecommerce platforms.
Management Team
With over 160 years in Ammolite management, operations, and sales, GEMXX possesses an unparalleled wealth of knowledge and expertise. Its team members have extensive backgrounds in every facet of the Ammolite business, allowing the company to excel in product development, maintain rigorous quality control measures, and maximize profitability. The breadth and depth of the GEMXX team’s experience enable the company to navigate the industry with precision, ensuring that GEMXX remains at the forefront of the Ammolite market. GEMXX leverages its collective wisdom to drive innovation, deliver exceptional products, and optimize business strategies to achieve long-term success.
Jay Maull is Founder, CEO and Chairman of GEMXX. With a career spanning more than three decades, he has been deeply involved in the Ammolite industry, from mining and production to marketing. He has owned and operated the world’s largest Ammolite mine and has delivered exceptional Ammolite products to customers across all continents. He has also established the world’s largest Ammolite ecommerce platform.
Richard Clowater is President of GEMXX. He is a skilled sales and marketing professional with a focus on research, data analysis and strategic planning. He has successfully implemented initiatives to expand markets, boost profits and foster customer loyalty. He has an impressive track record of negotiating sales and contracts worth over $250 million with influential stakeholders, including key purchasing personnel, C-suite executives and government entities at all levels.
Tom Dryden is a Vice President of GEMXX and brings a wealth of experience and expertise to the production and marketing of Ammolite, spanning over 30 years. His extensive involvement in the industry has granted him unparalleled knowledge of the Bearpaw Ammonite bearing formations. As a recognized authority in the field, Mr. Dryden’s research and papers on Canadian Ammonites have garnered global recognition, being published worldwide. In his role at GEMXX, Mr. Dryden assumes the responsibility of overseeing the company’s Canadian-based production facilities.
P. K. Chung is Business Manager Asia at GEMXX. With a track record of over 25 years in Ammolite business management, production and marketing in Asia, she is a recognized authority in the industry. Based in the Hong Kong gem district, she possesses an intricate understanding of the Asian gem and jewelry markets, including market dynamics, consumer preferences and industry trends specific to the region. Her strategic insights and deep connections enable GEMXX to thrive in this influential market.
GEMXX Corp. (OTC: GEMZ), closed Tuesday's trading session at $0.02675, even for the day. The average volume for the last 3 months is and the stock's 52-week low/high is $0.0172/$0.19.
Recent News
- GEMXX Corp. (OTC: GEMZ) - GEMXX Corp. (GEMZ) Plans to Fully Harness Potential of Two Promising Target Basins in Latin America, Bolstered by Recent Strategic Addition to Primary Investment Target's Board
- TinyGemsBreaks - GEMXX Corp. (GEMZ), Partner Positioned to Establish Footprint in Global Oil and Gas Market
- InvestorNewsBreaks - GEMXX Corp. (GEMZ) Announces Strategic Board Appointment
Horizon Fintex | Upstream
The QualityStocks Daily Newsletter would like to spotlight Horizon Fintex | Upstream
Last week Onyx by JP Morgan released a report detailing how it plans on leveraging Web3 for online shopping. According to the report, the idea is to create a more secure, transparent, trustworthy shopping experience for customers. The social-commerce market, valued at more than $1 trillion, is expected to grow by 600% by 2030. This is indeed a rapid expansion, thanks to the convenience of social media. The report shows that as of this year, more than five billion people are actively participating on social media platforms, presenting an excellent opportunity for businesses to advertise and sell their products. But why Web3? Nonetheless, the future of JP Morgan's Onyx is still bright. Its foray into Web3 and social commerce could pave the way for a new era of online shopping — one where shoppers feel secure, informed and in control of their shopping experience. Entities in other business verticals, such as Horizon Fintex, are also leveraging Web3 technologies within their suite of products. Collectively, the efforts by different actors could accelerate the rate at which Web3 is adopted and becomes a normal part of life.
Horizon Fintex is a software business specializing in compliant securities solutions. The company aims to facilitate the future of capital markets by leveraging the regulatory experience of Wall Street bankers and the proven track record of technology veterans to bring focus to compliance, efficiency, security and transparency.
Horizon’s flagship product is the revolutionary trading app ‘Upstream’, a MERJ Exchange Market, and the first regulated market powered by a blockchain to offer both digital securities and NFT trading. Upstream traders experience T+0 settlement, best bids and offers displayed on a transparent public orderbook that prevents predatory market practices – all from a user-friendly trading app.
Products
Horizon Fintex offers a full suite of end-to-end blockchain-enhanced software solutions to create a seamless experience for both issuers and investors. Its product suite includes:
- Securitization & Issuance – ETSware is an end-to-end Electronic Trading System streamlining capital raising from primary issuance through compliant secondary trading.
- KYC Compliance Onboarding – KYCware is a white label Know Your Customer (KYC) and Anti-Money Laundering (AML) compliance software solution offering best-in-class cryptographic security to compliantly onboard and verify user identity through a smartphone application.
- AML Screening Software – AMLCop offers advanced Anti-Money Laundering (AML) software to streamline the verification of user details against a proprietary database of global sanctions, politically exposed persons (PEPs) and watchlists.
- Cap. Table Management Tools – CustodyWare equips registered U.S. transfer agents with next-generation cap. table management software to manage securities on behalf of their clients pursuant to an SEC-registered or exempt securities offering.
- Exchange & Trading App Technology – Open Order Book offers Ethereum blockchain securities exchange software to power the next generation of trading venues for digital assets.
Upstream – The Horizon-Powered Trading App
Upstream is a joint venture with MERJ Exchange (merj.exchange), an affiliate of the World Federation of Exchanges.
Upstream aims to be the premiere global trading hub offering issuers around the world exposure to a digital-first investor base that can trade using USDC digital currency along with credit, debit, PayPal, and USD (fiat) to increase liquidity and enhance price discovery; while also offering investors access to dual-listed companies, IPOs, crowdfunded companies, U.S. & Int’l. equities, digital coupons and NFTs directly from a user-friendly trading app.
Upstream aims to unlock liquidity for investors of all levels while offering industry-leading levels of transparency, accessibility and investor protections enforced using Ethereum blockchain technology.
Management Team
Brian Collins is the CEO of Horizon Fintex. He founded the company in 2010. From 1999-2010, Mr. Collins was CEO of Abbey Technology in Switzerland, specializing in the design of trading software for Swiss banks. Prior to this, he worked for Credit Suisse in Zürich, designing and building proprietary equity trading solutions. Mr. Collins graduated in 1990 with a BS in Computer Systems from the University of Limerick, Ireland.
Mark Elenowitz is the company’s President. He is a Wall Street veteran with over 29 years of experience. Mr. Elenowitz was the co-founder of a U.S. broker dealer and is Managing Director of two U.S. broker dealers, responsible for advising clients on compliance, capital structure and capital market navigation. He was responsible for leading the first successful Reg A+ IPO of a company to list on the NYSE and others which listed directly onto Nasdaq. He is a noted speaker at Small Cap and Reg A events, including the SEC Small Business Forum, and has been profiled in BusinessWeek and CNBC, as well as several other publications. Mr. Elenowitz is a graduate of the University of Maryland School of Business and Management with a BS in Finance and holds Series 24, 62, 63, 79, 82 and 99 licenses.
Dr. Andrew Le Gear is the CTO of Horizon Fintex. Prior to joining the company in 2013, he worked as a software engineer with Dell Inc. (2012-2013) and Lehman Brothers and Nomura Plc. (2007-2012). Dr. Le Gear was a co-founder of Juneberi Ltd., a research-driven software tech start-up (2004-2007). He graduated in 2006 with a Ph.D. in Computer Science from the University of Limerick, Ireland.
Peter Hall is the company’s CIO. Prior to joining Horizon Fintex in 2011, he worked at Microsoft (2008-2011), Atos Origin (2004-2008) and AIT Group Plc. (1998-2002). Mr. Hall has held CISSP certification since 2010. He graduated from the University of Sheffield, UK in 1995 and earned an MS from the University College London in 2006.
Mike Boswell is the CFO of Horizon Fintex. A Wall Street veteran, he co-founded a U.S. broker dealer and served as Chief Compliance Officer. Mr. Boswell was also Managing Director of TriPoint Capital Advisors, a merchant banking and financial consulting company, and CFO of Mission Solutions Group, a privately held defense sector firm. He earned an MBA from John Hopkins University and a BS in Mechanical Engineering from the University of Maryland. Mr. Boswell holds Series 24, 62, 63, 79, 82 and 99 licenses.
Recent News
Annovis Bio Inc. (NYSE: ANVS)
The QualityStocks Daily Newsletter would like to spotlight Annovis Bio Inc. (NYSE: ANVS).
Annovis Bio (NYSE: ANVS), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative disorders such as Alzheimer's ("AD") and Parkinson's disease ("PD"), today announced receipt of approval from the U.S. Food and Drug Administration ("FDA") to transition to a new solid form of buntanetap in future clinical trials. "In June 2024, Annovis announced the filing of a composition of matter patent for the new crystal form of buntanetap and a provisional patent for the manufacturing process of this new form," the announcement reads. "The company conducted comprehensive bridge studies in various solvents and in animals, comparing the old semi-crystalline form with the new crystalline form of buntanetap. Additionally, Annovis developed an innovative large-scale manufacturing process for the new form. This comprehensive data was submitted to the FDA for review."
To view the full press release, visit https://ibn.fm/bK7Qw
Annovis Bio Inc. (NYSE: ANVS) is a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative disorders such as Alzheimer’s Disease (AD) and Parkinson’s Disease (PD). Annovis Bio stands out by developing a drug that targets multiple neurotoxic proteins simultaneously, aiming to restore axonal and synaptic activity. This innovative approach aims to treat memory loss and dementia associated with AD and body and brain dysfunction associated with PD, making Annovis a unique player in the neurodegeneration space.
Lead Drug Candidate: Buntanetap
Buntanetap (formerly Posiphen) targets neurodegeneration by inhibiting the formation of multiple neurotoxic proteins, including amyloid beta, tau, alpha-synuclein, and TDP43. This multifaceted inhibition improves synaptic transmission and axonal transport, reduces neuroinflammation, and protects nerve cells from dying. Unlike monoclonal antibody therapies, Buntanetap is an orally available small molecule capable of inhibiting multiple neurotoxic proteins at once, positioning it as a comprehensive solution for neurodegenerative diseases.
In a recent Phase II/III Alzheimer’s study, Buntanetap demonstrated statistically significant efficacy. Patients with early AD showed a significantly higher rate of improvement in ADAS-Cog 11 scores across all treatment doses compared to placebo, with a -3.3 point improvement compared to -0.3 for placebo (p < 0.01). Plasma Tau protein levels also reduced, consistent with previous Phase II biomarker data, further validating Buntanetap’s mechanism of action.
Similarly, in the Phase III study of Buntanetap in patients with early Parkinson’s disease, significant advancements were observed. Topline data results are anticipated in June 2024. Preliminary findings indicate promising results in improving cognitive and motor function, underscoring Buntanetap’s potential as a transformative therapy for Parkinson’s disease.
Market Opportunity
The aging population presents a significant market opportunity, with nearly 7 million Americans currently suffering from Alzheimer’s Disease (AD), a figure projected to rise to almost 13 million by 2050 (Alzheimer’s Association) (Republican Policy Committee). Additionally, approximately 1.2 million people in the U.S. have Parkinson’s Disease (SingleCare).
The economic burden of Alzheimer’s is immense, with care costs expected to reach $360 billion in 2024 and escalate to nearly $1 trillion annually by 2050. The need for effective, comprehensive treatments like Buntanetap is more critical than ever.
Company Highlights
- Innovative Therapeutic Approach: Annovis Bio uniquely targets multiple neurotoxic proteins, aiming to restore nerve cell health and improve cognitive and motor function in AD and PD patients.
- Robust Clinical Data: Phase II/III studies show significant improvements in cognitive function and biomarker levels in early AD patients.
- Groundbreaking Clinical Insights: Preliminary results from Phase II studies indicate significant improvements in motor functions and speed in patients with Parkinson’s Disease (PD).
- Upcoming Phase III Trials: Plans are underway for an 18-month Phase III trial focusing on biomarker-positive early AD patients, designed to further validate Buntanetap’s disease-modifying potential.
- Capital Efficiency: Annovis Bio is capital-efficient, with zero debt and multiple global patents extending into the 2040s.
Management Team
Maria L. Maccecchini, Ph.D., Founder, President, CEO, and Executive Board Member, founded Annovis Bio in May 2008 with the mission to develop better therapeutics for Alzheimer’s, Parkinson’s, and other neurodegenerative diseases. She has previously been a partner and director at two angel groups, Robin Hood Ventures and MidAtlantic Angel Group, and founded Symphony Pharmaceuticals/Annovis, which was sold to Transgenomic in 2001. Her extensive experience includes roles such as General Manager at Bachem Bioscience and Head of Molecular Biology at Mallinckrodt. Dr. Maccecchini holds a Ph.D. in biochemistry from the Biocenter of Basel, with postdoctoral work at Caltech and the Roche Institute of Immunology.
Cheng Fang, Ph.D., Senior VP of Research and Development, is an accomplished neuroscientist with two decades of experience in neurodegenerative diseases. She has a successful track record of scientific publications and contributions, coupled with extensive pre-clinical and clinical development experience. Dr. Fang has been instrumental in advancing the understanding of neurodegenerative disease mechanisms and developing therapeutic strategies.
Michael Christie, Ph.D., VP of Process Chemistry, has over 40 years of experience in the pharmaceutical industry, focusing on process chemistry R&D, pilot plant production, and GMP operations. He has held senior management positions at companies such as SmithKline, Rhodia, Teva, and Cephalon, and founded a contract process R&D service company, which was later acquired by ChiRex. Dr. Christie is co-author or co-inventor on several publications and patents. He earned his BS in chemistry from the University of Michigan and his doctorate from MIT.
Melissa Gaines, Senior VP of Clinical Operations, is an accomplished clinical research professional with over 20 years of experience across academia, contract research organizations, and pharmaceutical companies. She has proven abilities in monitoring and managing Phase I to IV clinical trials, specializing in CNS disorders and extending to a broad range of therapeutic indications. Her CNS experience spans from small Phase I and II studies to large global Phase III trials in Alzheimer’s disease, Parkinson’s disease, sleep disorders, and various psychiatric diseases in both adult and pediatric populations. In her current role, she oversees and supports all clinical project activities, driving operational success and ensuring high-quality clinical outcomes.
Learn more about the Annovis Bio team on LinkedIn.
Annovis Bio Inc. (NYSE: ANVS), closed Tuesday's trading session at $12.51, off by 1.0285%, on 961,197 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $4.53/$22.49.
Recent News
- Annovis Bio Inc. (NYSE: ANVS) - InvestorNewsBreaks - Annovis Bio Inc. (NYSE: ANVS) Secures FDA Approval for New Form of Buntanetap
- InvestorNewsBreaks - Annovis Bio Inc. (NYSE: ANVS) Names Four New Members to Executive Team
- InvestorNewsBreaks - Annovis Bio Inc. (NYSE: ANVS) Releases Significant Findings from Phase 3 Parkinson's Study, Schedules Webcast
Mullen Automotive Inc. (NASDAQ: MULN)
The QualityStocks Daily Newsletter would like to spotlight Mullen Automotive Inc. (MULN).
Mullen Automotive (NASDAQ: MULN), an electric vehicle ("EV") manufacturer, and its subsidiary, Bollinger Motors, have announced changes in Bollinger management. According to the announcement, former General Motors ("GM") executive James Taylor has been appointed CEO, replacing company founder Robert Bollinger; Bollinger, a major shareholder, will remain on the company's board of directors. Bryan Chambers was also named president and chief operating officer with Siva Kumar appointed chief strategy officer and senior vice president of finance. Taylor has been working with Bollinger on development of the company's all-electric Bollinger B4 Class 4 Chassis Cab. He has more than three decades of experience in the automotive industry and has served in leadership positions with several companies, including Cadillac and Hummer. He has also gained impressive experience in the EV space, working with companies such as Electric Last Mile Solutions, Workhorse, Karma, SF Motors and Mullen. Both Chambers and Kumar were already working at Bollinger Motors. Chambers joined the company in 2018, serving most recently as COO. Kumar joined Bollinger in 2022 as chief financial officer. Bollinger Motors develops class 4–6 all-electric commercial chassis cab trucks. "I am grateful and excited for this opportunity to continue moving Bollinger Motors toward a leadership role in the electric vehicle industry," said Bollinger Motors CEO James Taylor in the press release. "Robert and his team have done an incredible job of creating a world-class electric truck with the Bollinger B4 and the upcoming Bollinger B5. The response from the market has been very encouraging, and we are well-positioned to disrupt the Class 4 trucking market."
To view the full press release, visit https://ibn.fm/NNUbw
Mullen Automotive Inc. (NASDAQ: MULN) is a Southern California-based automotive company that owns and partners with several synergistic businesses working toward the unified goal of creating clean and scalable energy solutions. Mullen has evolved over the past decade in sync with consumers and technology trends. Today, the company is working diligently to provide exciting EV options built entirely in the United States and made to fit perfectly into the American consumer’s life. Mullen strives to make EVs more accessible than ever by building an end-to-end ecosystem that takes care of all aspects of EV ownership.
Commencement of Trading on Nasdaq
On November 5, 2021, Mullen announced its commencement of trading on the Nasdaq Capital Market.
“Today is a monumental day for Mullen Automotive. I am especially proud of our team, investors and all who have believed in Mullen and taken us to this point as a publicly traded company on the Nasdaq Capital Market,” David Michery, CEO and Chairman of Mullen Automotive, stated in the news release. “Trading on Nasdaq now opens us up to new investors, both institutional and retail shareholders, and broadens our awareness and company profile, while increasing awareness of Mullen and our technology platform and opening new opportunities in EV and beyond. The road ahead has never been brighter for Mullen, and I am proud to lead us into the future.”
The milestone came in the wake of the company’s stock-for-stock merger with Net Element Inc.
The Mullen FIVE
The Mullen FIVE EV Crossover, debuting at the Los Angeles International Auto Show (LAIAS) on November 17, 2021, embodies Mullen’s Southern California roots with an inspired design focused on two complementary Golden State themes – California landscape and California urban.
The FIVE is built on an EV Crossover skateboard platform that offers multiple powertrain configurations and trim levels in a svelte design that is Strikingly Different™ and exciting to experience in person.
Prior to the start of LAIAS, the Mullen FIVE was selected as a finalist by the LA Auto Show for Top EV SUV in the ZEVA “People’s Choice” Awards.
LAIAS provides Mullen an opportunity to display multiple variants of the FIVE model while also showcasing its powertrain, battery and charging technology. The company intends to bring the FIVE to market in 2024, and reservations are currently open here.
Mullen’s development portfolio also includes EV Fleet Vans, which it intends to bring to market in Q2 2022, and the pure electric, high performance Mullen DragonFLY.
Expansion of Manufacturing Capacity
On November 2, 2021, Mullen announced plans to expand its facility in Robinsonville, Mississippi.
Mullen’s Advanced Manufacturing and Engineering Facility (AMEC) currently occupies 124,000 square feet of manufacturing space. The total available land on the property is over 100 acres, and Mullen is moving ahead with plans to build out another 1.2 million square feet of manufacturing space to support class 1 and class 2 EV cargo vans and the Mullen FIVE EV Crossover.
On the expanded site, Mullen plans to build a body shop, a fully automated paint shop and a general assembly shop.
EV Market Outlook
The global EV market was reported to consist of 3,269,671 units in 2019, a figure that is expected to grow at a CAGR of 21.1% through 2030 to a total of 26,951,318 units worldwide. This market’s monetary value was estimated at $162.34 billion in 2019 and is expected to grow at a CAGR of 22.6%, resulting in an approximate value of $802.81 billion by 2027. The primary driver for this exponential growth is a worldwide increase in vehicle emissions regulations.
Management Team
David Michery is the CEO and Founder of Mullen and has been leading the company and its divisions since inception in 2014. With over 25 years of executive management, marketing, distressed assets, and business restructuring experience, Mr. Michery brings a wealth of relevant knowledge and expertise to the Mullen brand. He has notably created 12 trademarks so far to develop the company brand and vision.
Mr. Michery is working toward a sustainable future accessible to all by creating a suite of clean-energy electric vehicles at varied price points. With entirely U.S.-based manufacturing and operations, he is also determined to have Mullen Technologies play a role in shaping a self-sustaining local economy by creating more jobs in America.
Mr. Michery manages risks and company expectations as a pathway to success and has personally overseen several businesses that totaled over $1 billion in transactions. His key strength is the ability to be fiscally responsible and lead teams to complete projects on time and within budget. As a seasoned professional in this space, Mr. Michery has demonstrated skill in building businesses from the ground up and into successful entities that subsequently sold for hundreds of millions of dollars.
Mullen Automotive Inc. (MULN), closed Tuesday's trading session at $1.85, off by 7.0352%, on 4,771,912 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $1.80/$155.70.
Recent News
- Mullen Automotive Inc. (NASDAQ: MULN) - Mullen Announces POWER BOOST, Industry-First Solid-State Polymer Battery Pack Exchange Program
- Company Makes Progress in Building Storm-Resistant Clean-Energy System for Tropical Locations
- InvestorNewsBreaks - Mullen Automotive Inc. (NASDAQ: MULN) Announces Approximately $825K Vehicle Order for B4 EV Chassis Cabs
CNS Pharmaceuticals Inc. (NASDAQ: CNSP)
The QualityStocks Daily Newsletter would like to spotlight CNS Pharmaceuticals Inc. (NASDAQ: CNSP).
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, will be featured in tomorrow's Virtual Investor Closing Bell Series. According to the announcement, CNS Pharmaceuticals CEO John Climaco will be presenting via a live video webcast at 4 p.m. on July 17. The presentation will include a corporate overview and will also feature a live question-and-answer period. A replay of the webcast will be available following the live presentation and will be accessible for 90 days.
To view the presentation, visit https://ibn.fm/Uy7c6
To view the full press release, visit https://ibn.fm/oHoJW
CNS Pharmaceuticals Inc. (NASDAQ: CNSP) is a clinical stage biotechnology company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system.
The company was founded in 2017 and is headquartered in Houston, Texas.
Organ Targeted Therapeutics
The company’s lead drug candidate, Berubicin, is proposed for the treatment of glioblastoma multiforme (“GBM”), an aggressive and incurable form of brain cancer. Berubicin also has potential to treat other central nervous system malignancies. Based on limited clinical data, Berubicin appears to be the first anthracycline to cross the blood brain barrier in the adult brain, and it was the subject of a successful Phase 1 study which found the MDT and produced efficacy data as well.
CNS holds a worldwide exclusive license to the Berubicin chemical compound. The company has acquired all requisite data and know-how from Reata Pharmaceuticals Inc. related to a completed Phase I clinical trial of Berubicin in malignant brain tumors. In this trial, 44% of patients experienced a statistically significant improvement in clinical benefit. In 2017, CNS entered into a collaboration and asset purchase agreement with Reata.
CNS intends to explore the potential of Berubicin to treat other diseases, including pancreatic and ovarian cancers and lymphoma. The company is also examining plans to develop combination therapies that include Berubicin.
CNS estimates that more than $25 million in private capital and grants were invested in Berubicin prior to the company’s $9.8 million IPO in November 2019.
CNS intends to submit an IND for Berubicin during the fourth quarter of 2020 and expects to commence a Phase II clinical trial of Berubicin for the treatment of GBM in the U.S. in Q1 2021. A sub-licensee partner was awarded a $6 million EU/Polish National Center for Research and Development grant to undertake a Phase II trial of Berubicin in adults and a first-ever Phase I trial in pediatric GBM patients in Poland in 2021.
The company’s second drug candidate, WP1244, is a novel DNA binding agent licensed from the MD Anderson Cancer Center. In preclinical studies, WP1244 proved to be 500-times more potent than the chemotherapeutic agent, daunorubicin, in inhibiting tumor cell proliferation. The company has entered into a sponsored research agreement with the MD Anderson Cancer Center to further the development of WP1244.
CNS Pharmaceuticals recently engaged U.S.-based Pharmaceutics International Inc. and Italian BSP Pharmaceuticals SpA for the production of the Berubicin drug product. The company has implemented a dual-track manufacturing strategy to mitigate COVID-19-related risks, diversify its supply chain and provide for localized availability of Berubicin. CNS has already completed synthesis of Berubicin’s active pharmaceutical ingredient (API) and has shipped the API to both manufacturers in order to prepare an injectable form of Berubicin for clinical use.
Global Brain Tumor Therapeutics Market
The high recurrence rate of malignant brain tumors is due to reappearance of focal masses, indicating that a sub-population of tumor cells in these cancers may be insensitive to current therapies and may be responsible for reinitiating tumor growth. This necessitates the development of newer drugs in the market that demonstrate greater efficacy in treating such aggressive cancers.
A global increase in neurological disorders has placed increased attention on cancers of the brain over the past decade. Neurological disorders are becoming one of the most prevalent types of disorders, due to longer life expectancy, greater exposure to infection and an increasingly sedentary lifestyle. Because few treatments for primary and metastatic cancers of the brain exist, costs are high and have acted as a restraint for the brain tumor therapeutics market.
Despite progress in surgery, radiotherapy and chemotherapeutic strategies, effective treatments for brain cancer are limited by a lack of specific therapies for the brain and the difficulty in transporting therapeutic compounds across the blood brain barrier. Therefore, there is a significant need for novel and effective therapeutic drugs and strategies that prolong survival and improve quality of life for brain tumor patients.
Several companies are making significant investments into R&D, which is expected to bring more treatment options to the market in the near future. Industry reports consistently project continued growth in the market.
One report estimates that the global brain tumor therapeutics market will reach a valuation of $2.74 billion in 2023, with the market expected to register a CAGR of 11% during the forecast period from 2018 to 2023. Another report projects that the global brain tumor therapeutics market will reach $3.4 billion by 2025, up from $2.25 billion in 2019 (http://nnw.fm/eDUjp).
Management Team
John M. Climaco is the CEO of CNS Pharmaceuticals. For 15 years, Climaco has served in leadership roles for a variety of health care companies. Recently, Climaco served as the Executive Vice President of Perma-Fix Medical S.A, where he managed the development of a novel method to produce Technitium-99. Climaco also served as President and CEO of Axial Biotech Inc., a DNA diagnostics company. In the process of taking Axial from inception to product development to commercialization, Climaco forged strategic partnerships with Medtronic, Johnson & Johnson and Smith & Nephew.
Christopher Downs, CPA, is the company’s Chief Financial Officer. Downs previously served as Interim Chief Financial Officer and Executive Vice President of InfuSystem Holdings Inc. (NYSE: INFU), a supplier of infusion services to oncologists in the United States. Downs holds a Bachelor of Science from the United States Military Academy at West Point, an MBA from Columbia Business School and a Master of Science in Accounting from the University of Houston-Clear Lake.
Dr. Donald Picker is the Chief Scientific Officer of CNS. Picker has over 35 years of drug development experience. Prior to joining CNS, Picker worked at Johnson Matthey, where he was responsible for the development of Carboplatin, one of the world’s leading cancer drugs, which was acquired by Bristol-Myers Squibb with annual sales of over $500 million. In addition, he oversaw the development of Satraplatin and Picoplatin, third-generation platinum drugs currently in late-stage clinical development.
Sandra L. Silberman, M.D., Ph.D., is the Chief Medical Officer of CNS Pharmaceuticals. Silberman is a hematologist/oncologist who earned her B.A., Sc.M. and Ph.D. from the Johns Hopkins University School of Arts and Sciences, School of Public Health and School of Medicine, respectively, and her M.D. from Cornell University Medical College. She then completed both a clinical fellowship in hematology/oncology and a research fellowship in tumor immunology at the Brigham & Women’s Hospital and the Dana Farber Cancer Institute in Boston, Massachusetts. Silberman has played key roles in the development of many drugs, including Gleevec(TM), for which she led the global clinical development at Novartis. Silberman advanced several original, proprietary compounds into Phases I through III during her work with leading biopharmaceutical companies, including Bristol-Myers Squibb, AstraZeneca, Imclone and Roche.
CNS Pharmaceuticals Inc. (NASDAQ: CNSP), closed Tuesday's trading session at $1.11, off by 5.9322%, on 422,203 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $1.00/$6875.00.
Recent News
- CNS Pharmaceuticals Inc. (NASDAQ: CNSP) - InvestorNewsBreaks - CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Exec to Present at Upcoming Virtual Investor Closing Bell Series
- Research Identifies How Glioblastoma Develops Resistance to Immunotherapy
- InvestorNewsBreaks - CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Pricing of Registered Direct, Concurrent Private Placement
Correlate Energy Corp. (OTCQB: CIPI)
The QualityStocks Daily Newsletter would like to spotlight Correlate Energy Corp. (OTCQB: CIPI).
Correlate Energy Corp. (OTCQB: CIPI) is a publicly-traded company strategically positioned to capitalize on America’s unstoppable trend toward decentralized energy generation.
The energy grid in the U.S. is insufficient for the booming clean energy trend, and current infrastructure is limiting green energy distribution. Constructing the needed infrastructure to address this demand imbalance will cost billions and be far too slow, positioning decentralized systems, like those on offer from Correlate, in a key position for heightened demand.
Correlate has identified several key economic drivers powering the decentralized energy trend, including:
- Real Cost Savings – Customer pays zero money down and gets an instant electrical price discount to current rates.
- Massive Project Investment Funding – The International Energy Agency estimates that over one billion dollars per day will be invested in solar energy in 2023.
- Consistent Long-Term Incentives – The Inflation Reduction Act is a game-changer, supercharging renewables with $1.2 trillion in tax credits for 10 years of market support.
- Robust Customer Demand – Wood Mackenzie expects the U.S. solar industry to nearly triple in size over the next five years.
Correlate’s team of multi-decade experts who have worked with renowned global brands are positioning the company to make the most of this opportunity while consolidating a fragmented industry. Collectively, the team has developed, financed and deployed over $2 billion in clean energy projects to date.
Three-Pronged Strategy
Correlate is leveraging a three-pronged strategy aimed at driving shareholder value:
- Sell – Correlate seeks to finance, develop and profitably sell localized clean energy solutions and microgrids to industrial, commercial and residential customers.
- Retain – Correlate plans to retain ownership of some of these energy systems and thereby realize ongoing, reliable cash flow.
- Acquire – Correlate seeks to acquire proven renewable energy companies in order to exponentially grow earnings per share for investors.
This strategy is enhanced by current investment trends. Clean energy earnings are being sought after by investors. In Q4 2022, the median EBITDA multiple for green energy companies was 12.3x, according to Finerva.
Market Outlook
Over the next decade and beyond, renewable energy growth is expected to come primarily via decentralized systems like those offered by Correlate.
The Inflation Reduction Act enacted in late August 2022 is likewise expected to drive growth for the company by providing new tax incentives that reduce costs for clients and/or elevate returns to investors.
Commercial buildings consume more than 35% of the generated electricity in the U.S. and are underperforming in energy efficiency at every level. These buildings waste energy, emit too much carbon and are too costly for owners and occupants, but retrofits are not happening at the rate or scale needed.
In today’s real estate market, portfolio property owners own most commercial buildings, yet most building efficiency work is focused on single buildings, thereby missing the distinct needs of this owner class which are very different from traditional owner-occupiers. The diverse nature of commercial buildings, combined with technology and performance uncertainty, make simple energy optimization initiatives – which could greatly reduce energy use and improve building value – financially unattractive, resulting in slow adoption rates. CIPI’s financial instruments and software breakdown this issue, known as the ‘split incentive’, unlocking the majority of the addressable market.
A key portion of Correlate’s strategy relates to consolidation of what has been a fragmented industry. By uncovering opportunities to improve efficiencies through strategic M&A activities, the company intends to enhance profitability throughout its operations.
Management Team
Todd Michaels is President and CEO of CIPI and founder of Correlate. He formerly served as Vice President for Innovation at SunEdison and Senior Director Distributed Solar at NRG Energy. He founded Correlate in 2015 and has 16 years of experience in the energy industry. He graduated from Indiana University with a B.S. in Computer Information Systems.
Channing Chen is CFO at CIPI and Correlate Inc. and brings over 16 years of experience in the solar industry as a developer, financier, and business unit leader. He has held executive management roles at Solar Power Partners (acquired by NRG Energy), where he was a founding employee, SunEdison, and NRG Energy (NYSE: NRG). Most recently, Mr. Chen was founder and Managing Partner at Breakaway Energy Partners LLC – a distributed energy financing and market-making platform. To date, Mr. Chen and his teams have raised over $1.5 billion in financing across residential, commercial, and utility scale solar and energy storage projects representing over 400 MWs. He holds a B.A. in Environmental Chemistry from the University of California at San Diego and an MBA from the University of Southern California. He is also an advisor and early-stage investor to several startup companies in the renewable energy space.
Dave Bailey is Chief Revenue Officer of Correlate Inc. With over 15 years of executive sales, supply chain management, and energy efficiency experience, he is responsible for ensuring the success of the National Commercial Sales Unit across multiple regional project teams. Mr. Bailey created and launched the Transformation Services team while at Wesco for its multibillion-dollar Distributed Energy Resource division, formerly Westinghouse. His focus was on IoT-enabled efficiency and plant floor automation-based services. Before that, he spent several years in Global Account Sales Management, with GE Supply as a Program Manager, and is a Commercial Leadership Program graduate. Mr. Bailey received his B.S. in Mechanical Engineering from the University of Kentucky.
Jed Freedlander is the company’s Chief Development Officer. He has a background in infrastructure development and investment and a strong legal, commercial and finance acumen. Mr. Freedlander has a proven track record in leading complex public-private partnership (P3) and energy transactions and is instrumental in driving Correlate’s strategic development initiatives.
Roger Baum is Executive VP Operations at Correlate. With over 20 years of experience at Core Construction, he brings to the company a wealth of knowledge and a strong track record in delivering successful commercial construction projects.
Jason Loyet is Director of Solar Energy for Correlate Inc. He is a cleantech executive with over 20 years of experience leading high growth solar energy and software start-ups. Mr. Loyet is a U.S. Department of Energy SunShot Catalyst award winner for his work building the Solar Site Design technology platform. Before joining the solar energy industry in 2005, he founded and sold two software companies in the streaming media (GlobalStreams) and newspaper publishing (MyCapture) industries. Mr. Loyet currently serves as a Member of the Board of Directors for the Tennessee Solar Energy Industry Association (TenneSEIA).
Correlate Energy Corp. (OTCQB: CIPI), closed Tuesday's trading session at $0.44, up 25.7143%, on 4,533 volume. The average volume for the last 3 months is 6,932 and the stock's 52-week low/high is $0.05/$2.35.
Recent News
- Correlate Energy Corp. (OTCQB: CIPI) - New UK Government Cancels Onshore Wind Farms Ban
- GreenEnergyBreaks - Correlate Energy Corp. (CIPI) Expanding Solutions to Significant Untapped Market
- Correlate Energy Corp. (CIPI) Subsidiary Enters Key Partnership in Nation's First Microgrid Utility
Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF)
The QualityStocks Daily Newsletter would like to spotlight Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF).
Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF) is a strategic minerals company focused on locating and developing economic properties in the strategic metals and advanced materials space. The company aims to improve domestic specialty mineral infrastructure efficiencies to meet surging national demand from North American manufacturers, effectively positioning itself as one of the only North American suppliers of high purity natural graphite for hi-tech applications.
Reflex Advanced Materials is based in Vancouver, British Columbia. Its project portfolio includes the Ruby Graphite Deposit in Montana and the ZigZag Lithium Property in Ontario.
Projects
Ruby Graphite Project
Located in a mining-friendly jurisdiction in southwest Montana, the Ruby Graphite Deposit is a low cost, rapid re-entry opportunity that produced roughly 2,400 tons of graphite from 1902 to 1948. Reflex Advanced Materials holds mining rights for 755 hectares at the Ruby Graphite Project, with 96 federal lode mining claims. Recent samples assay at 95.8% to 98.4% total carbon.
The site is notable as the only combined U.S. graphite flake and vein graphite source. Vein graphite is ideal for energy storage applications, because it requires fewer steps to achieve purity than synthetic alternatives and is therefore far less environmentally damaging. This is expected to play a key role in the project’s development as demand for electric vehicles continues to surge.
In March 2023, the company announced its submittal of permit applications to the Bureau of Land Management in respect of its exploration of the Ruby Graphite Project. Its initial drill program, expected to take place in the summer of 2023, includes plans for 3,500 total meters of drilling, cored to an average depth of 130 meters. The targets for this drill program have been identified using historical data from original mine operations and data gathered for the initial 43-101 technical report on the project, dated January 31, 2023.
ZigZag Lithium Property
Located in the Thunder Bay Mining Division of Ontario, the ZigZag Lithium Property consists of eight mining claims spanning roughly 2,710 hectares. Mineralization at the property, most notably lithium, is based in pegmatite dikes and concentrated in spodumene crystals, which are consistent throughout the entire unit.
Spodumene is readily observable in outcrops and in drill cores, with crystal sizes ranging from 3-15cm, on average.
Reflex Advanced Materials and American Energy Technologies Company Metallurgical Partnership
Reflex Advanced Materials has entered into a material processing agreement with American Energy Technologies Co., which is based in Arlington Heights, Illinois, to conduct metallurgical testwork with the goal of creating a technical support data package for Reflex’s target customer base, U.S. Federal agencies and qualification programs with hi-tech customers in the battery and battery storage business.
The resulting coated, spherionized, purified graphite (CSPG) material that is expected to be created from the aforementioned tests will be used to provide potential customers of CSPG with samples so that they can begin the material qualification process.
Market Opportunity
Graphite is an ideal battery anode and has dominated the market since the proliferation of lithium-ion batteries. Despite this demand, there is currently no significant production of lithium-ion battery anode material in North America.
Instead, most graphite sold in North America today is sourced from Chinese producers. U.S. President Joe Biden highlighted this sourcing disparity in a 2022 address:
“The United Stated depends on unreliable foreign sources for many of the strategic and critical materials necessary for the clean energy transition – such as lithium, nickel, cobalt, graphite and manganese for large-capacity batteries,” he said. “Demand for such materials is projected to increase exponentially as the world transitions to a clean energy economy.”
The U.S. Department of Energy is in the process of awarding $2.8 billion to expand domestic manufacturing of batteries for electric vehicles and combat this foreign dependency. Reflex Advanced Materials has identified its Ruby Graphite Project as a prime candidate for U.S.-sponsored initiatives due to the rarity and scarcity of natural graphite deposits in the country.
Processing graphite domestically in the U.S. is expected to provide Reflex Advanced Materials a competitive advantage as manufacturers begin to seek out American supply in the face of increased diplomatic tension. This is critical, as a rise in anode demand is expected to fuel a shortage of 8 million tonnes of graphite by 2040. World Bank Group projects 494% growth in total graphite demand by 2050.
Leadership Team
Paul Gorman is the CEO and a Director of Reflex Advanced Materials. He brings to the company over 25 years of experience in junior mining finance, public listings, viability assessment and operational rationalization. For 18 years, Mr. Gorman served as president and managing partner of Riverbank Capital, where he played an instrumental role in raising more than $85 million for small-cap companies. In 2008, he funded Industrial Minerals Inc. (later Northern Graphite) and served in an advisory role for four other graphite companies, contributing significantly to the revitalization of the junior graphite space in North America. Mr. Gorman founded Mega Graphite Inc. in 2009 and has served as chief executive for three other companies.
Tasheel Jeerh, CPA, is the company’s CFO. He is a finance and accounting professional with over a decade of experience spanning both public and private sectors. Prior to joining Reflex Advanced Materials, Mr. Jeerh played a pivotal role in the growth of a private upstream oil and gas firm, dealing with over $2 billion in M&A activity and $1 billion in financing activities. He gained his designation at PricewaterhouseCoopers, where he worked as a manager in the assurance practice.
Greg Bell is Project Manager for Reflex Advanced Materials. He is a multi-disciplined engineering management professional with more than 40 years of experience in the natural resources sector. Mr. Bell has successfully built and managed several start-up operations in various capacities. He has been active in graphite and lithium exploration for the past seven years.
Christopher W. Hill leads the company’s Corporate Development initiatives. He is an investor and entrepreneur with over a decade of experience in the capital markets. Mr. Hill began his career as an investment advisor and then began to consult and advise private companies on their paths to becoming publicly traded. He specializes in corporate development and strategic financing utilizing his large network in the capital markets.
Reflex Advanced Materials Corp. (RFLXF), closed Tuesday's trading session at $0.0495, up 35.6164%, on 20,201 volume. The average volume for the last 3 months is 24,179 and the stock's 52-week low/high is $0.0306/$0.35.
Recent News
- Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF) - European Climate Survey Reports Older Adults Have Better Grasp of the Environment
- Moody's, MSCI Team Up to Boost Transparency in ESG Data
- New Report Discusses Graphite Market's Prospects Between 2024-2035
Freight Technologies Inc. (NASDAQ: FRGT)
The QualityStocks Daily Newsletter would like to spotlight Freight Technologies Inc. (NASDAQ: FRGT).
Freight Technologies Inc. (NASDAQ: FRGT) (“Fr8Tech”) is a technology company developing solutions to optimize and automate the supply chain process, providing a platform for B2B cross-border shipping in the NAFTA region. The company’s mission is to revolutionize cross-border shipping by providing carriers with increased growth opportunities and shippers with flexibility, visibility and simplicity for the once-complex process of international over-the-road shipping.
Freight Technologies, formerly known as Hudson Capital Inc., assumed its current name and ticker symbol on May 27, 2022. Its primary operating subsidiary and its marketplace are known as Fr8App, and it conducts operations throughout North America under the names of Fr8App and/or Freight App. The company is headquartered in Houston, Texas, with multiple locations across the U.S. and Mexico.
The Fr8Tech Solutions Suite
Fr8Tech leverages artificial intelligence to provide cloud-based platforms aimed at automating the over-the-road transportation process, effectively reducing human touch points and expediting load booking times. The company’s suite of solutions includes:
- Fr8app – A B2B marketplace powered by AI and Machine Learning offering a real-time broker portal to connect shippers with qualified carriers
- Fr8Radar – A tracking solution providing shippers and carriers real-time locational data via Fr8app’s mobile solution or through integration with third-party GPS alternatives
- Fr8TMS – A transportation management system designed to help shippers manage their freight and all of the documents involved in shipping transactions, including invoices, customs documents, confirmation rates and proof of deliveries
- Fr8FMS – A fleet management system allowing transportation companies to better manage their fleets, reduce operational costs and provide better service to their customers
- Fr8Data – A data solution offering real-time dashboards and reports to shippers and carriers in an effort to increase visibility and control while supporting better business decisions
- Fr8Fleet – A platform that provides private fleet management, enabling large corporate shippers to purchase dedicated capacity secured by Fr8app in exchange for a fixed fee
Commitment to the Environment
Through its core focus on technology, Fr8Tech seeks to reduce the carbon footprint of the logistics industry. Its solutions aim to minimize empty miles for transportation firms and reduce overall paper consumption.
Fr8University
Fr8University is an educational program offering classroom and on-the-job training for Fr8Tech team members. Through the program, employees learn in-depth business fundamentals and applications along the truckload freight industry value chain.
Led by corporate educator Mario Mena, Fr8University is designed as an investment in the company’s human capital, providing an opportunity to communicate Fr8Tech’s corporate culture while accelerating operational growth.
Market Outlook
Fr8Tech’s established foothold in Mexico is key to its current efforts to promote sustainable growth in the cross-border shipping industry. Ongoing disruption in U.S.-Chinese trade relations have strengthened Mexico’s status as the largest trading partner of the U.S., with cross-border annual freight spending estimated at $385 billion according to data from the U.S. Department of Transportation. Annual domestic shipping in Mexico is estimated at $34 billion, while annual domestic shipping in the U.S. is estimated to total $732 billion.
Despite the size of this industry, fragmentation and inefficiencies prevail in the space. Thousands of legacy brokers, tens of thousands of shippers and hundreds of thousands of carriers still rely on outdated systems to arrange transport, spending hours on the phone negotiating pricing, waiting days to find trucks and drivers, preparing and printing forms, and operating without tracking or visibility. Add in cross-border complexity relating to customs and additional paperwork, and you have an industry ripe for technological disruption.
Fr8Tech’s recent revenue growth trends have highlighted the company’s efforts to capitalize on this opportunity. In 2021, Fr8Tech achieved revenues of $21.5 million, marking a year-over-year increase of 134%. The company issued revenue guidance for fiscal 2022 of $40 million in a February 9, 2022, press release, which would account for a further 86% year-over-year increase.
Management Team
Javier Selgas is CEO and a Director of Freight Technologies Inc. and Freight App Inc. He brings to the company over 15 years of experience developing technology and digital marketing strategies, including serving as Country Manager for Osigu, Spain, and as head of AJEgroup’s IT division for the Asia-Pacific region. Prior to joining Fr8Tech, Mr. Selgas founded digital marketing agency Lanzadera Online. He has also served as an IT consultant to major corporations, including Endesa and Ibermatica.
Mike Flinker is President of Fr8Tech. He has over four decades of experience in the transportation industry, with 30+ years focused on cross-border logistics. Prior to joining Fr8Tech, Mr. Flinker founded FLS Transportation, the largest cross-border logistics company in Canada. He also previously held positions with Clarke Transport Inc., Canadian Pacific and Reimer Express Inc. (a division of Roadway Express).
Paul Freudenthaler is the company’s CFO and Secretary to the company Board. He has over 30 years of financial expertise, having previously served as CFO for several leading companies across multiple countries, including Macquarie in Mexico, Old Mutual in Latin America and Ascentium Capital in the U.S. Mr. Freudenthaler’s experience include leadership roles from which he guided IPOs and M&A transactions.
Luisa Lopez is COO of Fr8Tech. She brings to the company 25+ years of management experience in logistics, supply chain, operations and customer service. Ms. Lopez previously served as a Director of Landstar, where she was responsible for commercial and client development strategies in the Mexican market. Additionally, she managed more than 2,000 transport units specialized in staff and school mobility while with Traxion in Mexico.
Freight Technologies Inc. (NASDAQ: FRGT), closed Tuesday's trading session at $0.3, up 5.7828%, on 2,131,157 volume. The average volume for the last 3 months is 5.202M and the stock's 52-week low/high is $0.28/$14.00.
Recent News
- Freight Technologies Inc. (NASDAQ: FRGT) - InvestorNewsBreaks - Freight Technologies Inc. (NASDAQ: FRGT) Unveils Revolutionary State-of-the-Art Platform for Digital Ocean-Freight Booking, Management
- InvestorNewsBreaks - Freight Technologies Inc. (NASDAQ: FRGT) Further Strengthens Business Relationship with Amazon Mexico
- InvestorNewsBreaks - Freight Technologies Inc. (NASDAQ: FRGT) Completes Presentation at Chardan Transport Platform Tech Series
The QualityStocks Numbers Report
The QualityStocks Sponsored News
- 180 Life Sciences Corp. (NASDAQ: ATNF) - InvestorNewsBreaks - 180 Life Sciences Corp. (NASDAQ: ATNF) Granted Extension to Regain Compliance with Nasdaq Listing Requirements
- Aditxt Inc. (NASDAQ: ADTX) - InvestorNewsBreaks - Aditxt Inc.'s (NASDAQ: ADTX) Merger Target Expects 'Fourth Consecutive Year of Net Sales Growth'
- Advanced Gold Exploration Inc. (CSE: AUEX) (FSE: 4TG) (OTC: AUHIF) - InvestorNewsBreaks - Advanced Gold Exploration Inc. (CSE: AUEX) Management to Attend Upcoming Global Mining Investment Conference
- Amesite Inc. (NASDAQ: AMST) - InvestorNewsBreaks - Amesite Inc. (NASDAQ: AMST) Announces Beta Enrollment for New App Designed to Enhance Personal Safety, Security
- Appia Rare Earths & Uranium Corp. (CSE: API) (OTCQX: APAAF) - InvestorNewsBreaks - Appia Rare Earths & Uranium Corp. (CSE: API) (OTCQX: APAAF) (FSE: A0I0) (MUN: A0I0) (BER: A0I0) Begins Drilling at Uranium-Bearing Loranger Property
- Fresh2 Group Ltd. (NASDAQ: FRES) - Appointment of New Independent Director
- Astiva Health - InvestorNewsBreaks – Astiva Health Providing Tailored Approach to Healthcare
- Arizona Metals Corp. (TSX: AMC) (OTCQX: AZMCF) - Copper Producers Start Paying Attention to 'Urban Mining'
- Astrotech Corp. (NASDAQ: ASTC) - TechMediaBreaks - Astrotech Corporation (NASDAQ: ASTC) Sets New Standard for Accuracy, Reliability in Narcotics Detection
- Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) - Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) Outlines Plans for Fully Funded Exploration Program at Epworth Project
- Augmedix Inc. (NASDAQ: AUGX) - Augmedix Partners with Google Cloud to Bring Medically-Tuned AI Technology to Ambient Documentation
- Battery Mineral Resources Corp. (TSX.V: BMR) (OTCQB: BTRMF) - InvestorNewsBreaks - Battery Mineral Resources Corp. (TSX.V: BMR) (OTCQB: BTRMF) Subsidiary Closes on Second Drawdown of Credit Facility
- Bebuzee Inc. (OTC: BBUZ) - TechMediaBreaks - Bebuzee Inc. (BBUZ) Bringing Future of Digital Engagement Through Game-Changing Super App
- BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) - InvestorNewsBreaks - BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Releases Shareholder Update with Corporate, Operational Highlights
- Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) - InvestorNewsBreaks - Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Releases Successful Preclinical Results In-Vivo Proof-of-Concept Psoriatic Human Skin Model Study
- Bravo Multinational Inc. (OTC: BRVO) - TechMediaBreaks - Bravo Multinational Inc. (BRVO) Tapping into Growth Projected Within Various Segments of the Streaming Market
- BioNxt Solutions Inc. (CSE: BNXT) (OTCQB: BNXTF) (FSE: 4XT) - InvestorNewsBreaks - BioNxt Solutions Inc. (CSE: BNXT) (OTCQB: BNXTF) (FSE: BXT) Announces Highly Promising Results from ODF Cladribine PK Study
- Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) - InvestorNewsBreaks - Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Collaborates to Open Gold Circulation Channels
- Btab Ecommerce Group Inc. (OTC: BBTT) - InvestorNewsBreaks - Btab Ecommerce Group Inc. (BBTT) to Strengthen Global Support for Small Businesses via Business Combination Agreement
- Canada Nickel Company Inc. (TSX.V: CNC) (OTCQX: CNIKF) - InvestorNewsBreaks - Canada Nickel Company Inc. (TSX.V: CNC) (OTCQX: CNIKF) Announces Creation of 'ExploreCo' to Unlock Value from Significant Asset Portfolio
- Cepton Inc. (NASDAQ: CPTN) - InvestorNewsBreaks - Cepton Inc. (NASDAQ: CPTN) Releases Q1 2024 Financial Report, Business Update
- CISO Global, Inc. (NASDAQ: CISO) - InvestorNewsBreaks - CISO Global Inc. (NASDAQ: CISO) Partners with Fortegra to Offer Protection Plans for Cybersecurity Clients
- Clene Inc. (NASDAQ: CLNN) - InvestorNewsBreaks - Clene Inc. (NASDAQ: CLNN) Management Slated to Participate in Upcoming Emerging Growth Conference
- CNS Pharmaceuticals Inc. (NASDAQ: CNSP) - InvestorNewsBreaks - CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Exec to Present at Upcoming Virtual Investor Closing Bell Series
- Correlate Energy Corp. (OTCQB: CIPI) - New UK Government Cancels Onshore Wind Farms Ban
- Coyuchi Inc. - Investment Advisor Warns That Politicizing ESG Isn’t Sustainable
- Cub Crafters Inc. - InvestorNewsBreaks – CubCrafters Inc. CEO Eyes Bright Future for Fleet Sales Program
- Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) - InvestorNewsBreaks - Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Sees "Swell" of Insider Investments, Upgrade in Ranking after Positive Year-End Report
- DarioHealth Corp. (NASDAQ: DRIO) - InvestorNewsBreaks - DarioHealth Corp. (NASDAQ: DRIO) Collaborates to Expand GLP-1 Solution
- Diamond Lake Minerals Inc. (OTC: DLMI) - InvestorNewsBreaks - Diamond Lake Minerals Inc. (DLMI) Enters Million-Dollar Share Exchange Agreement with Horizon Fintex
- Data443 Risk Mitigation Inc. (OTC: ATDS) - InvestorNewsBreaks - Data443 Risk Mitigation Inc. (ATDS) to Provide Updated Open-Source Offering, Threat-Intelligence Data to SORBS Community
- D-Wave Quantum Inc. (NYSE: QBTS) - Samsung Anticipates Profit Jump After Incorporating AI
- Electronic Servitor Publication Network Inc. (OTCQB: XESP) - Electronic Servitor Publication Network Inc. (XESP) Combines Powerful Digital Engagement Engine(TM) with Simple Pricing Model to Drive Growth of Client Companies
- ECGI Holdings Inc. (OTC: ECGI) - ECGI Holdings Inc. (ECGI) Aligning Operations to Target Faster and Consistent Growth Trajectory Down Proven Path
- Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) - Unconventional Market Factors Cause Gold Market to Rise
- Emperor Metals Inc. (CSE: AUOZ) (FRA:9NH) (OTCQB: EMAUF) - InvestorNewsBreaks - Emperor Metals Inc. (CSE: AUOZ) (OTCQB: EMAUF) (FRA: 9NH) Reports on Plans to Explore Eastern Extent at Duquesne West Gold Project
- Energy and Water Development Corp. (OTCQB: EAWD) - Energy and Water Development Corp. (EAWD) Offers an Off-grid Solution to Combat Clean Water Access Challenges Brought About by Climate Change
- Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) - InvestorNewsBreaks - Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Announces Strategic Appointment of Former Critical Minerals Leader from General Motors
- EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) - InvestorNewsBreaks - EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF) Signs 20-Year RNG Offtake Agreement with FortisBC, Secures Feedstock Supply Agreement
- Exro Technologies Inc. (TSX: EXRO) (OTCQB: EXROF) - InvestorNewsBreaks - Exro Technologies Inc.'s (TSX: EXRO) (OTCQB: EXROF) Reports on Shareholder Voting Held During 2024 Annual General Meeting
- FingerMotion Inc. (NASDAQ: FNGR) - How DePINS Could Disrupt the Global Telecoms Industry
- Fintech Ecosystem Development Corp. (NASDAQ: FEXD) - InvestorNewsBreaks - Fintech Ecosystem Development Corp. (NASDAQ: FEXD) Carving out Share in Challenger Bank, Crypto Markets
- First Tellurium Corp. (CSE: FTEL) (OTCQB: FSTTF) - Concerns Grow Regarding Market Consolidation as Moody's Exits ESG Ratings Segment
- Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) - InvestorNewsBreaks - Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) Releases Core Review Report on 'Blue Sky' Potential at Mal Lake
- FE Battery Metals Corp. (CSE: FE) (OTCQB: FEMFF) - InvestorNewsBreaks - FE Battery Metals Corp. (CSE: FE) (OTC: FEMFF) Report Positive Lab Results from Augustus Lithium Project Testwork
- Flora Growth Corp. (NASDAQ: FLGC) - InvestorNewsBreaks - Flora Growth Corp. (NASDAQ: FLGC) Announces Acquisition of Australian Vaporizers
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) - InvestorNewsBreaks - Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Partners with BuilderX Robotics for POC Project
- Freight Technologies Inc. (NASDAQ: FRGT) - InvestorNewsBreaks - Freight Technologies Inc. (NASDAQ: FRGT) Unveils Revolutionary State-of-the-Art Platform for Digital Ocean-Freight Booking, Management
- GEMXX Corp. (OTC: GEMZ) - GEMXX Corp. (GEMZ) Plans to Fully Harness Potential of Two Promising Target Basins in Latin America, Bolstered by Recent Strategic Addition to Primary Investment Target's Board
- FuelPositive Corp. (TSX.V: NHHH) (OTC: NHHHF) - Can Green Energy Replicate Sense of Culture, Community That Coal Mining Nurtured?
- GeoSolar Technologies Inc. - QualityStocksNewsBreaks – GeoSolar Technologies Inc. Taking Part in Shift Toward a Greener Future
- GivBux Inc. (OTC: GBUX) - InvestorNewsBreaks - GivBux Inc. (GBUX) Moves to Qualify as OTCQB Corporation
- Golden Matrix Group Inc. (NASDAQ: GMGI) - InvestorNewsBreaks - Golden Matrix Group Inc.'s (NASDAQ: GMGI) Releases Q2 Financial Report, Reports Record Revenue
- Golden Triangle Ventures Inc. (OTC: GTVH) - Golden Triangle Ventures Inc. (GTVH), Lavish Entertainment Report on Progress of One-of-a-Kind Entertainment Destination
- GolfLync Inc. - InvestorNewsBreaks - GolfLync Inc. Reaches 100K Membership Milestone, Sees 3,033% Growth Rate in 2023
- Genprex Inc. (NASDAQ: GNPX) - InvestorNewsBreaks - Genprex Inc. (NASDAQ: GNPX) Announces Participation at Upcoming Investor, Industry Events
- RYVYL Inc. (NASDAQ: RVYL) - InvestorNewsBreaks - RYVYL Inc. (NASDAQ: RVYL) Announces Agreement to Extend Repayment Date on Convertible Note
- HeartBeam Inc. (NASDAQ: BEAT) - InvestorNewsBreaks - HeartBeam Inc. (NASDAQ: BEAT) Now Listed on Russell Microcap Index
- HealthLynked Corp. (OTCQB: HLYK) - InvestorNewsBreaks - HealthLynked Corp. (HLYK) Announces New COO, Appoints Seasoned Veteran to Enhance Operations and Drive Initiatives
- Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTD) (FRA: 7HIA.F) - InvestorNewsBreaks - Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTF) (FSE: 7HI) Launches Prototype to Showcase ZVS Tech
- Horizon Fintex | Upstream - JP Morgan’s Onyx Mulls Leveraging Web3 for Social Commerce
- iClick Interactive Asia Group Ltd. (NASDAQ: ICLK) - InvestorNewsBreaks - iClick Interactive Asia Group Limited (NASDAQ: ICLK) Names New Board Member, Audit Committee Chair
- Ideanomics Inc. (NASDAQ: IDEX) - InvestorNewsBreaks - Ideanomics Inc. (NASDAQ: IDEX) Releases Financial Report for Q4, FY 2023
- IGC Pharma Inc. (NYSE American: IGC) - InvestorNewsBreaks - IGC Pharma Inc.'s (NYSE American: IGC) TGR-63 Demonstrates Blood-Brain Barrier Permeability in Preliminary Findings
- Infobird Co., Ltd (NASDAQ: IFBD) - InvestorNewsBreaks - Infobird Co. Ltd. (NASDAQ: IFBD) Announces Delayed Effective Date of Reverse Split
- InMed Pharmaceuticals Inc. (NASDAQ: INM) - BioMedNewsBreaks - InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Significant Improvements from INM-089 in AMD, Validates INM-901 as Potential AD Treatment
- Safety Shot Inc. (NASDAQ: SHOT) - InvestorNewsBreaks - Safety Shot (NASDAQ: SHOT) Cuts Ties with Brand Ambassador, Reinforces 'Zero Tolerance' for Discrimination and Hate Speech
- BlockQuarry Corp. (OTC: BLQC) - InvestorNewsBreaks - BlockQuarry Corp (BLQC) Looking Toward Future with Pivotal Shift to AI-Driven Data Storage, High-Performance Computing
- Knightscope (NASDAQ: KSCP) - InvestorNewsBreaks - Knightscope, Inc. (NASDAQ: KSCP) Launches New K1 Laser Solution for Physical Security
- Laredo Oil Inc. (OTC: LRDC) - InvestorNewsBreaks - Laredo Oil Inc. (LRDC) Subisidary Begins Drilling on Well in Montana-Based Midfork Location
- Longeveron Inc. (NASDAQ: LGVN) - InvestorNewsBreaks - Longeveron Inc.'s (NASDAQ: LGVN) Lomecel-B(TM) Granted RMAT Designation for the Treatment of Mild Alzheimer's Disease
- Lexaria Bioscience Corp. (NASDAQ: LEXX) - InvestorNewsBreaks - Lexaria Bioscience Corp. (NASDAQ: LEXX) Makes Management Announcement, Plans for Strategic Growth
- Life Electric Vehicles Holdings Inc. (OTC: LFEV) - InvestorNewsBreaks - Life Electric Vehicles Holdings Inc. (LFEV) Engages IBN for Corporate Communications Expertise
- Lottery.com Inc. (NASDAQ: LTRY) - InvestorNewsBreaks - Lottery.com Inc. (NASDAQ: LTRY) Enters Agreement with New Strategic Financial Adviser
- LQwD Technologies Corp. (TSX.V: LQWD) (OTCQB: LQWDF) - InvestorNewsBreaks - LQWD Technologies Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Reports on Status of Bitcoin Lightning Network Operations
- Lucy Scientific Discovery Inc. (NASDAQ: LSDI) - Neuroscience Study Shows Psychedelic-Assisted Therapy Causes Rapid Changes in Brain
- McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) - MiningNewsBreaks - McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Positioned as Standout Opportunity for Investors
- MetAlert Inc. (OTC: MLRT) - Researchers Find Balancing Ability May Predict Risk of Cognitive Decline
- Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) - MIND CURE HEALTH INC. ANNOUNCES CLOSING OF THE FIRST TRANCHE OF LNG ENERGY GROUP'S SUBSCRIPTION RECEIPT FINANCING
- Mydecine Innovations Group Inc. (NEO: MYCO) (FSE: 0NFA) (OTC: MYCOF) - InvestorNewsBreaks - Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Board Approves Issuance of Shares for Debt Settlement
- Nemaura Medical Inc. (NASDAQ: NMRD) - InvestorNewsBreaks - Nemaura Medical Inc. (NASDAQ: NMRD) Announces Positive Nasdaq Listing Decision
- NextPlat Corp. (NASDAQ: NXPL) (NASDAQ: NXPLW) - Web3 Users Surge 40% in Q2, Reach Historic High
- Nightfood Holdings Inc. (OTCQB: NGTF) - Service on the Rise: How Automation and Nightfood Holdings Inc. (NGTF) are Redefining Hospitality
- Nowigence Inc. (OTCQB: NOWG) - Nowigence Inc. (NOWG) Starts Trading on OTC
- Nutriband Inc. (NASDAQ: NTRB) - InvestorNewsBreaks - Nutriband Inc. (NASDAQ: NTRB) Obtains Notice of Allowance for Key Trademark Identified as 'Integral' to Platform Technology
- OK Stone Engineering Inc. - InvestorNewsBreaks — OK Stone Engineering Partners with Oren Klaff at Special Investor Event
- Mullen Automotive Inc. (NASDAQ: MULN) - Mullen Announces POWER BOOST, Industry-First Solid-State Polymer Battery Pack Exchange Program
- PaxMedica Inc. (NASDAQ: PXMD) - BioMedNewsBreaks - PaxMedica Inc. (PXMD) Intensifying Efforts to Achieve Significant Program Milestones
- PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) - InvestorNewsBreaks - PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTC: PLTXF) Amends Proposed 1-to-35 Share Consolidation
- Playgon Games Inc. (TSX.V: DEAL) (OTC: PLGNF) - InvestorNewsBreaks - Playgon Games Inc. (TSX.V: DEAL) (OTC: PLGNF) (FSE: 7CR) Receives Recognition for 'Pushing the Boundaries of Live Dealer Gaming'
- PowerTap Hydrogen Capital Corp. (NEO: MOVE) (FWB: 2K6A) (OTC: MOTNF) - InvestorNewsBreaks - PowerTap Hydrogen Capital Corp. (NEO: MOVE) (OTC: MOTNF) Releases Biweekly Status Update
- Predictive Oncology (NASDAQ: POAI) - InvestorNewsBreaks - Predictive Oncology Inc. (NASDAQ: POAI) Unveils Novel Technology, Eyes Significant Partnership Opportunities
- Pressure BioSciences Inc. (PBIO) - InvestorNewsBreaks - Pressure BioSciences Inc. (PBIO), Vita-Forte Collaborate to Commercialize Highly Potent UST Nanoemulsion Oral Spray
- Processa Pharmaceuticals Inc. (NASDAQ: PCSA) - InvestorNewsBreaks - Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Positive Efficacy Results from Phase 1b Trial
- Progressive Care Inc. (OTCQB: RXMD) - InvestorNewsBreaks - Progressive Care Inc. (RXMD) Releases Q1 2024 Financial Report Showing Record Revenue
- Prospera Energy Inc. (TSX.V: PEI) (FRA: OF6B) (OTC: GXRFF) - InvestorNewsBreaks - Prospera Energy Inc. (TSX.V: PEI) (OTC: GXRFF) (FRA: OF6B) Has 550,000 Common Shares Acquired by Investor
- Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) - InvestorNewsBreaks - Red White & Bloom Brands Inc. (CSE: RWB) (OTC: RWBYF) Files Documents Reporting Financial Results for Q4, FY 2023
- Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF) - European Climate Survey Reports Older Adults Have Better Grasp of the Environment
- Reunion Gold Corp. (TSX.V: RGD) (OTCQX: RGDFF) - InvestorNewsBreaks - Reunion Gold (TSX.V: RGD) (OTCQX: RGDFF) Announces Completion of Business Combination with G Mining Ventures
- REZYFi, Inc. - InvestorNewsBreaks – REZYFi Inc. Using Diversified Approach to Capitalize on Growth in Multiple Verticals
- RJD Green Inc. (OTC: RJDG) - InvestorNewsBreaks - RJD Green Inc. (RJDG) Eyes Additional Revenue, Profit Opportunities Through Silex Holdings Division
- N2OFF Inc. (NASDAQ: NITO) - InvestorNewsBreaks - N2OFF Inc. (NASDAQ: NITO) Reports Reduction in N2O Emissions in Corn Cultivation
- Software Effective Solutions Corp. (OTC: SFWJ) - New Hemp Reference Material from NIST to Ensure Accuracy in Cannabis Measurement
- Sigyn Therapeutics Inc. (OTCQB: SIGY) - BioMedNewsBreaks - Sigyn Therapeutics Inc. (SIGY) Leveraging Portfolio to Overcome Current Limitations in Healthcare
- Silo Pharma Inc. (OTCQB: SILO) - InvestorNewsBreaks - Silo Pharma Inc. (NASDAQ: SILO) Announces Exclusive Global License to Develop, Manufacture, Commercialize Alzheimer Drug
- SUIC Worldwide Holdings Ltd. (OTC: SUIC) - SUIC Worldwide Holdings Ltd. (SUIC) Using Technology and Financing to Magnify Potential and Opportunities of Promising Businesses
- SuperCom Ltd. (NASDAQ: SPCB) - Wearable, Unobtrusive, High-performing Technology Gives SuperCom Ltd. (NASDAQ: SPCB) Key Advantages in EM Offender Tracking Market
- Siyata Mobile Inc. (NASDAQ: SYTA) - InvestorNewsBreaks - Siyata Mobile Inc. (NASDAQ: SYTA), Zello Partner to Integrate Top-Rated App and SD7 Handset
- SOBRsafe Inc. (NASDAQ: SOBR) - SOBRsafe Inc. (NASDAQ: SOBR) Secures Two New Agreements to Provide Its Next-Generation Transdermal Alcohol Detection Solutions to Customers in Behavioral Health Segment
- Splash Beverage Group Inc. (NYSE American: SBEV) - InvestorNewsBreaks - Splash Beverage Group Inc. (NYSE American: SBEV) Partners to Expand Footprint in Colorado
- Standard Lithium Ltd. (NYSE American: SLI) - InvestorNewsBreaks - Standard Lithium Ltd. (TSX.V: SLI) (NYSE American: SLI) (FRA: S5L), Announces Participation in June Industry Events
- Starco Brands Inc. (OTCQB: STCB) - Whipshots® by Starco Brands Shatters Expectations with Explosive Growth and Nationwide Expansion
- StorEn Technologies Inc. - InvestorNewsBreaks – StorEn Technologies Inc. Recognized for Bringing Real Innovation to Vanadium Flow Batteries
- Vision Marine Technologies Inc. (NASDAQ: VMAR) - InvestorNewsBreaks - Vision Marine Technologies Inc. (NASDAQ: VMAR) Announces Strategic Collaboration, Expansion in Growing Electric Boat Rental Market
- SenesTech Inc. (NASDAQ: SNES) - SenesTech Inc. (NASDAQ: SNES) Scores Major Client with Evolve(TM) Deployment in the U.S. Virgin Islands
- Sekur Private Data Ltd. (FRA: GDT0) (CSE: SKUR) (OTCQB: SWISF) - InvestorNewsBreaks - Sekur Private Data Ltd. (CSE: SKUR) (OTCQX: SWISF) (FSE: GDT0) Spotlighted in Most Recent "New to the Street" Episode
- TAAT Global Alternatives Inc. (CSE: TAAT) (FRANKFURT: 2TP) (OTCQX: TOBAF) - InvestorNewsBreaks - TAAT(TM) Global Alternatives Inc. (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2) Plans 10-to-One Share Consolidation
- Tartisan Nickel Corp. (CSE: TN) (OTCQB: TTSRF) - Tartisan Nickel Corp. (CSE: TN) (OTCQB: TTSRF) (FSE: 8TA) Targets Rapid Global Growth in Nickel Demand
- SOBRsafe Inc. (NASDAQ: SOBR) - SOBRsafe Inc. (NASDAQ: SOBR) Secures Two New Agreements to Provide Its Next-Generation Transdermal Alcohol Detection Solutions to Customers in Behavioral Health Segment
- TRxADE HEALTH, INC. (NASDAQ: MEDS) - InvestorNewsBreaks - TRxADE Health Inc. (NASDAQ: MEDS) Announces Special Cash Dividend
- Torr Metals Inc. (TSX.V: TMET) - Copper Crunch Looms: Torr Metals Inc. (TSX.V: TMET) Makes Discoveries as Demand Outpaces Supply
- Trillion Energy International Inc. (CSE: TCF) (OTCQB: TRLEF) - InvestorNewsBreaks - Trillion Energy International Inc. (CSE: TCF) (OTCQB: TRLEF) Issues Update on SASB Program
- Turbo Energy S.A. (NASDAQ: TURB) - InvestorNewsBreaks - Turbo Energy S.A. (NASDAQ: TURB) Shares Results of 2024 Annual General Meeting
- Uranium Energy Corp. (NYSE American: UEC) - InvestorNewsBreaks - Uranium Energy Corp. (NYSE American: UEC) Reconfirms Position as America's Leading ISR Uranium Company with New TRS Filing
- Vision Marine Technologies Inc. (NASDAQ: VMAR) - InvestorNewsBreaks - Vision Marine Technologies Inc. (NASDAQ: VMAR) Announces Strategic Collaboration, Expansion in Growing Electric Boat Rental Market
- VistaGen Therapeutics Inc. (NASDAQ: VTGN) - InvestorNewsBreaks - Vistagen Therapeutics Inc. (NASDAQ: VTGN) Awarded New Patents from Four Countries to Broaden Global PH80 IP Portfolio
- Vivos Therapeutics Inc. (NASDAQ: VVOS) - InvestorNewsBreaks - Vivos Therapeutics Inc. (NASDAQ: VVOS) Reports Results of Seven-Month Provider-Based Marketing and Distribution Model Pilot
- Wrap Technologies Inc. (NASDAQ: WRAP) - Wrap Technologies, Inc. Bolsters BolaWrap® 150 Deployments, Promoting Safer Communities Nationwide
- Zoned Properties Inc. (ZDPY) - InvestorNewsBreaks - Zoned Properties Inc. (ZDPY) Expands Portfolio, Supports Growth of Cannabis Industry with Acquisition of Arizona Property
The QualityStocks DailyNetwork Sponsors
About The QualityStocks Daily
The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.
Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.
"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.
The QualityStocks Numbers Report
QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.
The QualityStocks Sponsored News
- 180 Life Sciences Corp. (NASDAQ: ATNF) - InvestorNewsBreaks - 180 Life Sciences Corp. (NASDAQ: ATNF) Granted Extension to Regain Compliance with Nasdaq Listing Requirements
- Aditxt Inc. (NASDAQ: ADTX) - InvestorNewsBreaks - Aditxt Inc.'s (NASDAQ: ADTX) Merger Target Expects 'Fourth Consecutive Year of Net Sales Growth'
- Advanced Gold Exploration Inc. (CSE: AUEX) (FSE: 4TG) (OTC: AUHIF) - InvestorNewsBreaks - Advanced Gold Exploration Inc. (CSE: AUEX) Management to Attend Upcoming Global Mining Investment Conference
- Amesite Inc. (NASDAQ: AMST) - InvestorNewsBreaks - Amesite Inc. (NASDAQ: AMST) Announces Beta Enrollment for New App Designed to Enhance Personal Safety, Security
- Appia Rare Earths & Uranium Corp. (CSE: API) (OTCQX: APAAF) - InvestorNewsBreaks - Appia Rare Earths & Uranium Corp. (CSE: API) (OTCQX: APAAF) (FSE: A0I0) (MUN: A0I0) (BER: A0I0) Begins Drilling at Uranium-Bearing Loranger Property
- Fresh2 Group Ltd. (NASDAQ: FRES) - Appointment of New Independent Director
- Astiva Health - InvestorNewsBreaks – Astiva Health Providing Tailored Approach to Healthcare
- Arizona Metals Corp. (TSX: AMC) (OTCQX: AZMCF) - Copper Producers Start Paying Attention to 'Urban Mining'
- Astrotech Corp. (NASDAQ: ASTC) - TechMediaBreaks - Astrotech Corporation (NASDAQ: ASTC) Sets New Standard for Accuracy, Reliability in Narcotics Detection
- Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) - Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) Outlines Plans for Fully Funded Exploration Program at Epworth Project
- Augmedix Inc. (NASDAQ: AUGX) - Augmedix Partners with Google Cloud to Bring Medically-Tuned AI Technology to Ambient Documentation
- Battery Mineral Resources Corp. (TSX.V: BMR) (OTCQB: BTRMF) - InvestorNewsBreaks - Battery Mineral Resources Corp. (TSX.V: BMR) (OTCQB: BTRMF) Subsidiary Closes on Second Drawdown of Credit Facility
- Bebuzee Inc. (OTC: BBUZ) - TechMediaBreaks - Bebuzee Inc. (BBUZ) Bringing Future of Digital Engagement Through Game-Changing Super App
- BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) - InvestorNewsBreaks - BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Releases Shareholder Update with Corporate, Operational Highlights
- Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) - InvestorNewsBreaks - Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Releases Successful Preclinical Results In-Vivo Proof-of-Concept Psoriatic Human Skin Model Study
- Bravo Multinational Inc. (OTC: BRVO) - TechMediaBreaks - Bravo Multinational Inc. (BRVO) Tapping into Growth Projected Within Various Segments of the Streaming Market
- BioNxt Solutions Inc. (CSE: BNXT) (OTCQB: BNXTF) (FSE: 4XT) - InvestorNewsBreaks - BioNxt Solutions Inc. (CSE: BNXT) (OTCQB: BNXTF) (FSE: BXT) Announces Highly Promising Results from ODF Cladribine PK Study
- Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) - InvestorNewsBreaks - Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Collaborates to Open Gold Circulation Channels
- Btab Ecommerce Group Inc. (OTC: BBTT) - InvestorNewsBreaks - Btab Ecommerce Group Inc. (BBTT) to Strengthen Global Support for Small Businesses via Business Combination Agreement
- Canada Nickel Company Inc. (TSX.V: CNC) (OTCQX: CNIKF) - InvestorNewsBreaks - Canada Nickel Company Inc. (TSX.V: CNC) (OTCQX: CNIKF) Announces Creation of 'ExploreCo' to Unlock Value from Significant Asset Portfolio
- Cepton Inc. (NASDAQ: CPTN) - InvestorNewsBreaks - Cepton Inc. (NASDAQ: CPTN) Releases Q1 2024 Financial Report, Business Update
- CISO Global, Inc. (NASDAQ: CISO) - InvestorNewsBreaks - CISO Global Inc. (NASDAQ: CISO) Partners with Fortegra to Offer Protection Plans for Cybersecurity Clients
- Clene Inc. (NASDAQ: CLNN) - InvestorNewsBreaks - Clene Inc. (NASDAQ: CLNN) Management Slated to Participate in Upcoming Emerging Growth Conference
- CNS Pharmaceuticals Inc. (NASDAQ: CNSP) - InvestorNewsBreaks - CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Exec to Present at Upcoming Virtual Investor Closing Bell Series
- Correlate Energy Corp. (OTCQB: CIPI) - New UK Government Cancels Onshore Wind Farms Ban
- Coyuchi Inc. - Investment Advisor Warns That Politicizing ESG Isn’t Sustainable
- Cub Crafters Inc. - InvestorNewsBreaks – CubCrafters Inc. CEO Eyes Bright Future for Fleet Sales Program
- Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) - InvestorNewsBreaks - Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Sees "Swell" of Insider Investments, Upgrade in Ranking after Positive Year-End Report
- DarioHealth Corp. (NASDAQ: DRIO) - InvestorNewsBreaks - DarioHealth Corp. (NASDAQ: DRIO) Collaborates to Expand GLP-1 Solution
- Diamond Lake Minerals Inc. (OTC: DLMI) - InvestorNewsBreaks - Diamond Lake Minerals Inc. (DLMI) Enters Million-Dollar Share Exchange Agreement with Horizon Fintex
- Data443 Risk Mitigation Inc. (OTC: ATDS) - InvestorNewsBreaks - Data443 Risk Mitigation Inc. (ATDS) to Provide Updated Open-Source Offering, Threat-Intelligence Data to SORBS Community
- D-Wave Quantum Inc. (NYSE: QBTS) - Samsung Anticipates Profit Jump After Incorporating AI
- Electronic Servitor Publication Network Inc. (OTCQB: XESP) - Electronic Servitor Publication Network Inc. (XESP) Combines Powerful Digital Engagement Engine(TM) with Simple Pricing Model to Drive Growth of Client Companies
- ECGI Holdings Inc. (OTC: ECGI) - ECGI Holdings Inc. (ECGI) Aligning Operations to Target Faster and Consistent Growth Trajectory Down Proven Path
- Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) - Unconventional Market Factors Cause Gold Market to Rise
- Emperor Metals Inc. (CSE: AUOZ) (FRA:9NH) (OTCQB: EMAUF) - InvestorNewsBreaks - Emperor Metals Inc. (CSE: AUOZ) (OTCQB: EMAUF) (FRA: 9NH) Reports on Plans to Explore Eastern Extent at Duquesne West Gold Project
- Energy and Water Development Corp. (OTCQB: EAWD) - Energy and Water Development Corp. (EAWD) Offers an Off-grid Solution to Combat Clean Water Access Challenges Brought About by Climate Change
- Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) - InvestorNewsBreaks - Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Announces Strategic Appointment of Former Critical Minerals Leader from General Motors
- EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) - InvestorNewsBreaks - EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF) Signs 20-Year RNG Offtake Agreement with FortisBC, Secures Feedstock Supply Agreement
- Exro Technologies Inc. (TSX: EXRO) (OTCQB: EXROF) - InvestorNewsBreaks - Exro Technologies Inc.'s (TSX: EXRO) (OTCQB: EXROF) Reports on Shareholder Voting Held During 2024 Annual General Meeting
- FingerMotion Inc. (NASDAQ: FNGR) - How DePINS Could Disrupt the Global Telecoms Industry
- Fintech Ecosystem Development Corp. (NASDAQ: FEXD) - InvestorNewsBreaks - Fintech Ecosystem Development Corp. (NASDAQ: FEXD) Carving out Share in Challenger Bank, Crypto Markets
- First Tellurium Corp. (CSE: FTEL) (OTCQB: FSTTF) - Concerns Grow Regarding Market Consolidation as Moody's Exits ESG Ratings Segment
- Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) - InvestorNewsBreaks - Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) Releases Core Review Report on 'Blue Sky' Potential at Mal Lake
- FE Battery Metals Corp. (CSE: FE) (OTCQB: FEMFF) - InvestorNewsBreaks - FE Battery Metals Corp. (CSE: FE) (OTC: FEMFF) Report Positive Lab Results from Augustus Lithium Project Testwork
- Flora Growth Corp. (NASDAQ: FLGC) - InvestorNewsBreaks - Flora Growth Corp. (NASDAQ: FLGC) Announces Acquisition of Australian Vaporizers
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) - InvestorNewsBreaks - Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Partners with BuilderX Robotics for POC Project
- Freight Technologies Inc. (NASDAQ: FRGT) - InvestorNewsBreaks - Freight Technologies Inc. (NASDAQ: FRGT) Unveils Revolutionary State-of-the-Art Platform for Digital Ocean-Freight Booking, Management
- GEMXX Corp. (OTC: GEMZ) - GEMXX Corp. (GEMZ) Plans to Fully Harness Potential of Two Promising Target Basins in Latin America, Bolstered by Recent Strategic Addition to Primary Investment Target's Board
- FuelPositive Corp. (TSX.V: NHHH) (OTC: NHHHF) - Can Green Energy Replicate Sense of Culture, Community That Coal Mining Nurtured?
- GeoSolar Technologies Inc. - QualityStocksNewsBreaks – GeoSolar Technologies Inc. Taking Part in Shift Toward a Greener Future
- GivBux Inc. (OTC: GBUX) - InvestorNewsBreaks - GivBux Inc. (GBUX) Moves to Qualify as OTCQB Corporation
- Golden Matrix Group Inc. (NASDAQ: GMGI) - InvestorNewsBreaks - Golden Matrix Group Inc.'s (NASDAQ: GMGI) Releases Q2 Financial Report, Reports Record Revenue
- Golden Triangle Ventures Inc. (OTC: GTVH) - Golden Triangle Ventures Inc. (GTVH), Lavish Entertainment Report on Progress of One-of-a-Kind Entertainment Destination
- GolfLync Inc. - InvestorNewsBreaks - GolfLync Inc. Reaches 100K Membership Milestone, Sees 3,033% Growth Rate in 2023
- Genprex Inc. (NASDAQ: GNPX) - InvestorNewsBreaks - Genprex Inc. (NASDAQ: GNPX) Announces Participation at Upcoming Investor, Industry Events
- RYVYL Inc. (NASDAQ: RVYL) - InvestorNewsBreaks - RYVYL Inc. (NASDAQ: RVYL) Announces Agreement to Extend Repayment Date on Convertible Note
- HeartBeam Inc. (NASDAQ: BEAT) - InvestorNewsBreaks - HeartBeam Inc. (NASDAQ: BEAT) Now Listed on Russell Microcap Index
- HealthLynked Corp. (OTCQB: HLYK) - InvestorNewsBreaks - HealthLynked Corp. (HLYK) Announces New COO, Appoints Seasoned Veteran to Enhance Operations and Drive Initiatives
- Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTD) (FRA: 7HIA.F) - InvestorNewsBreaks - Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTF) (FSE: 7HI) Launches Prototype to Showcase ZVS Tech
- Horizon Fintex | Upstream - JP Morgan’s Onyx Mulls Leveraging Web3 for Social Commerce
- iClick Interactive Asia Group Ltd. (NASDAQ: ICLK) - InvestorNewsBreaks - iClick Interactive Asia Group Limited (NASDAQ: ICLK) Names New Board Member, Audit Committee Chair
- Ideanomics Inc. (NASDAQ: IDEX) - InvestorNewsBreaks - Ideanomics Inc. (NASDAQ: IDEX) Releases Financial Report for Q4, FY 2023
- IGC Pharma Inc. (NYSE American: IGC) - InvestorNewsBreaks - IGC Pharma Inc.'s (NYSE American: IGC) TGR-63 Demonstrates Blood-Brain Barrier Permeability in Preliminary Findings
- Infobird Co., Ltd (NASDAQ: IFBD) - InvestorNewsBreaks - Infobird Co. Ltd. (NASDAQ: IFBD) Announces Delayed Effective Date of Reverse Split
- InMed Pharmaceuticals Inc. (NASDAQ: INM) - BioMedNewsBreaks - InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Significant Improvements from INM-089 in AMD, Validates INM-901 as Potential AD Treatment
- Safety Shot Inc. (NASDAQ: SHOT) - InvestorNewsBreaks - Safety Shot (NASDAQ: SHOT) Cuts Ties with Brand Ambassador, Reinforces 'Zero Tolerance' for Discrimination and Hate Speech
- BlockQuarry Corp. (OTC: BLQC) - InvestorNewsBreaks - BlockQuarry Corp (BLQC) Looking Toward Future with Pivotal Shift to AI-Driven Data Storage, High-Performance Computing
- Knightscope (NASDAQ: KSCP) - InvestorNewsBreaks - Knightscope, Inc. (NASDAQ: KSCP) Launches New K1 Laser Solution for Physical Security
- Laredo Oil Inc. (OTC: LRDC) - InvestorNewsBreaks - Laredo Oil Inc. (LRDC) Subisidary Begins Drilling on Well in Montana-Based Midfork Location
- Longeveron Inc. (NASDAQ: LGVN) - InvestorNewsBreaks - Longeveron Inc.'s (NASDAQ: LGVN) Lomecel-B(TM) Granted RMAT Designation for the Treatment of Mild Alzheimer's Disease
- Lexaria Bioscience Corp. (NASDAQ: LEXX) - InvestorNewsBreaks - Lexaria Bioscience Corp. (NASDAQ: LEXX) Makes Management Announcement, Plans for Strategic Growth
- Life Electric Vehicles Holdings Inc. (OTC: LFEV) - InvestorNewsBreaks - Life Electric Vehicles Holdings Inc. (LFEV) Engages IBN for Corporate Communications Expertise
- Lottery.com Inc. (NASDAQ: LTRY) - InvestorNewsBreaks - Lottery.com Inc. (NASDAQ: LTRY) Enters Agreement with New Strategic Financial Adviser
- LQwD Technologies Corp. (TSX.V: LQWD) (OTCQB: LQWDF) - InvestorNewsBreaks - LQWD Technologies Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Reports on Status of Bitcoin Lightning Network Operations
- Lucy Scientific Discovery Inc. (NASDAQ: LSDI) - Neuroscience Study Shows Psychedelic-Assisted Therapy Causes Rapid Changes in Brain
- McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) - MiningNewsBreaks - McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Positioned as Standout Opportunity for Investors
- MetAlert Inc. (OTC: MLRT) - Researchers Find Balancing Ability May Predict Risk of Cognitive Decline
- Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) - MIND CURE HEALTH INC. ANNOUNCES CLOSING OF THE FIRST TRANCHE OF LNG ENERGY GROUP'S SUBSCRIPTION RECEIPT FINANCING
- Mydecine Innovations Group Inc. (NEO: MYCO) (FSE: 0NFA) (OTC: MYCOF) - InvestorNewsBreaks - Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Board Approves Issuance of Shares for Debt Settlement
- Nemaura Medical Inc. (NASDAQ: NMRD) - InvestorNewsBreaks - Nemaura Medical Inc. (NASDAQ: NMRD) Announces Positive Nasdaq Listing Decision
- NextPlat Corp. (NASDAQ: NXPL) (NASDAQ: NXPLW) - Web3 Users Surge 40% in Q2, Reach Historic High
- Nightfood Holdings Inc. (OTCQB: NGTF) - Service on the Rise: How Automation and Nightfood Holdings Inc. (NGTF) are Redefining Hospitality
- Nowigence Inc. (OTCQB: NOWG) - Nowigence Inc. (NOWG) Starts Trading on OTC
- Nutriband Inc. (NASDAQ: NTRB) - InvestorNewsBreaks - Nutriband Inc. (NASDAQ: NTRB) Obtains Notice of Allowance for Key Trademark Identified as 'Integral' to Platform Technology
- OK Stone Engineering Inc. - InvestorNewsBreaks — OK Stone Engineering Partners with Oren Klaff at Special Investor Event
- Mullen Automotive Inc. (NASDAQ: MULN) - Mullen Announces POWER BOOST, Industry-First Solid-State Polymer Battery Pack Exchange Program
- PaxMedica Inc. (NASDAQ: PXMD) - BioMedNewsBreaks - PaxMedica Inc. (PXMD) Intensifying Efforts to Achieve Significant Program Milestones
- PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) - InvestorNewsBreaks - PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTC: PLTXF) Amends Proposed 1-to-35 Share Consolidation
- Playgon Games Inc. (TSX.V: DEAL) (OTC: PLGNF) - InvestorNewsBreaks - Playgon Games Inc. (TSX.V: DEAL) (OTC: PLGNF) (FSE: 7CR) Receives Recognition for 'Pushing the Boundaries of Live Dealer Gaming'
- PowerTap Hydrogen Capital Corp. (NEO: MOVE) (FWB: 2K6A) (OTC: MOTNF) - InvestorNewsBreaks - PowerTap Hydrogen Capital Corp. (NEO: MOVE) (OTC: MOTNF) Releases Biweekly Status Update
- Predictive Oncology (NASDAQ: POAI) - InvestorNewsBreaks - Predictive Oncology Inc. (NASDAQ: POAI) Unveils Novel Technology, Eyes Significant Partnership Opportunities
- Pressure BioSciences Inc. (PBIO) - InvestorNewsBreaks - Pressure BioSciences Inc. (PBIO), Vita-Forte Collaborate to Commercialize Highly Potent UST Nanoemulsion Oral Spray
- Processa Pharmaceuticals Inc. (NASDAQ: PCSA) - InvestorNewsBreaks - Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Positive Efficacy Results from Phase 1b Trial
- Progressive Care Inc. (OTCQB: RXMD) - InvestorNewsBreaks - Progressive Care Inc. (RXMD) Releases Q1 2024 Financial Report Showing Record Revenue
- Prospera Energy Inc. (TSX.V: PEI) (FRA: OF6B) (OTC: GXRFF) - InvestorNewsBreaks - Prospera Energy Inc. (TSX.V: PEI) (OTC: GXRFF) (FRA: OF6B) Has 550,000 Common Shares Acquired by Investor
- Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) - InvestorNewsBreaks - Red White & Bloom Brands Inc. (CSE: RWB) (OTC: RWBYF) Files Documents Reporting Financial Results for Q4, FY 2023
- Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF) - European Climate Survey Reports Older Adults Have Better Grasp of the Environment
- Reunion Gold Corp. (TSX.V: RGD) (OTCQX: RGDFF) - InvestorNewsBreaks - Reunion Gold (TSX.V: RGD) (OTCQX: RGDFF) Announces Completion of Business Combination with G Mining Ventures
- REZYFi, Inc. - InvestorNewsBreaks – REZYFi Inc. Using Diversified Approach to Capitalize on Growth in Multiple Verticals
- RJD Green Inc. (OTC: RJDG) - InvestorNewsBreaks - RJD Green Inc. (RJDG) Eyes Additional Revenue, Profit Opportunities Through Silex Holdings Division
- N2OFF Inc. (NASDAQ: NITO) - InvestorNewsBreaks - N2OFF Inc. (NASDAQ: NITO) Reports Reduction in N2O Emissions in Corn Cultivation
- Software Effective Solutions Corp. (OTC: SFWJ) - New Hemp Reference Material from NIST to Ensure Accuracy in Cannabis Measurement
- Sigyn Therapeutics Inc. (OTCQB: SIGY) - BioMedNewsBreaks - Sigyn Therapeutics Inc. (SIGY) Leveraging Portfolio to Overcome Current Limitations in Healthcare
- Silo Pharma Inc. (OTCQB: SILO) - InvestorNewsBreaks - Silo Pharma Inc. (NASDAQ: SILO) Announces Exclusive Global License to Develop, Manufacture, Commercialize Alzheimer Drug
- SUIC Worldwide Holdings Ltd. (OTC: SUIC) - SUIC Worldwide Holdings Ltd. (SUIC) Using Technology and Financing to Magnify Potential and Opportunities of Promising Businesses
- SuperCom Ltd. (NASDAQ: SPCB) - Wearable, Unobtrusive, High-performing Technology Gives SuperCom Ltd. (NASDAQ: SPCB) Key Advantages in EM Offender Tracking Market
- Siyata Mobile Inc. (NASDAQ: SYTA) - InvestorNewsBreaks - Siyata Mobile Inc. (NASDAQ: SYTA), Zello Partner to Integrate Top-Rated App and SD7 Handset
- SOBRsafe Inc. (NASDAQ: SOBR) - SOBRsafe Inc. (NASDAQ: SOBR) Secures Two New Agreements to Provide Its Next-Generation Transdermal Alcohol Detection Solutions to Customers in Behavioral Health Segment
- Splash Beverage Group Inc. (NYSE American: SBEV) - InvestorNewsBreaks - Splash Beverage Group Inc. (NYSE American: SBEV) Partners to Expand Footprint in Colorado
- Standard Lithium Ltd. (NYSE American: SLI) - InvestorNewsBreaks - Standard Lithium Ltd. (TSX.V: SLI) (NYSE American: SLI) (FRA: S5L), Announces Participation in June Industry Events
- Starco Brands Inc. (OTCQB: STCB) - Whipshots® by Starco Brands Shatters Expectations with Explosive Growth and Nationwide Expansion
- StorEn Technologies Inc. - InvestorNewsBreaks – StorEn Technologies Inc. Recognized for Bringing Real Innovation to Vanadium Flow Batteries
- Vision Marine Technologies Inc. (NASDAQ: VMAR) - InvestorNewsBreaks - Vision Marine Technologies Inc. (NASDAQ: VMAR) Announces Strategic Collaboration, Expansion in Growing Electric Boat Rental Market
- SenesTech Inc. (NASDAQ: SNES) - SenesTech Inc. (NASDAQ: SNES) Scores Major Client with Evolve(TM) Deployment in the U.S. Virgin Islands
- Sekur Private Data Ltd. (FRA: GDT0) (CSE: SKUR) (OTCQB: SWISF) - InvestorNewsBreaks - Sekur Private Data Ltd. (CSE: SKUR) (OTCQX: SWISF) (FSE: GDT0) Spotlighted in Most Recent "New to the Street" Episode
- TAAT Global Alternatives Inc. (CSE: TAAT) (FRANKFURT: 2TP) (OTCQX: TOBAF) - InvestorNewsBreaks - TAAT(TM) Global Alternatives Inc. (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2) Plans 10-to-One Share Consolidation
- Tartisan Nickel Corp. (CSE: TN) (OTCQB: TTSRF) - Tartisan Nickel Corp. (CSE: TN) (OTCQB: TTSRF) (FSE: 8TA) Targets Rapid Global Growth in Nickel Demand
- SOBRsafe Inc. (NASDAQ: SOBR) - SOBRsafe Inc. (NASDAQ: SOBR) Secures Two New Agreements to Provide Its Next-Generation Transdermal Alcohol Detection Solutions to Customers in Behavioral Health Segment
- TRxADE HEALTH, INC. (NASDAQ: MEDS) - InvestorNewsBreaks - TRxADE Health Inc. (NASDAQ: MEDS) Announces Special Cash Dividend
- Torr Metals Inc. (TSX.V: TMET) - Copper Crunch Looms: Torr Metals Inc. (TSX.V: TMET) Makes Discoveries as Demand Outpaces Supply
- Trillion Energy International Inc. (CSE: TCF) (OTCQB: TRLEF) - InvestorNewsBreaks - Trillion Energy International Inc. (CSE: TCF) (OTCQB: TRLEF) Issues Update on SASB Program
- Turbo Energy S.A. (NASDAQ: TURB) - InvestorNewsBreaks - Turbo Energy S.A. (NASDAQ: TURB) Shares Results of 2024 Annual General Meeting
- Uranium Energy Corp. (NYSE American: UEC) - InvestorNewsBreaks - Uranium Energy Corp. (NYSE American: UEC) Reconfirms Position as America's Leading ISR Uranium Company with New TRS Filing
- Vision Marine Technologies Inc. (NASDAQ: VMAR) - InvestorNewsBreaks - Vision Marine Technologies Inc. (NASDAQ: VMAR) Announces Strategic Collaboration, Expansion in Growing Electric Boat Rental Market
- VistaGen Therapeutics Inc. (NASDAQ: VTGN) - InvestorNewsBreaks - Vistagen Therapeutics Inc. (NASDAQ: VTGN) Awarded New Patents from Four Countries to Broaden Global PH80 IP Portfolio
- Vivos Therapeutics Inc. (NASDAQ: VVOS) - InvestorNewsBreaks - Vivos Therapeutics Inc. (NASDAQ: VVOS) Reports Results of Seven-Month Provider-Based Marketing and Distribution Model Pilot
- Wrap Technologies Inc. (NASDAQ: WRAP) - Wrap Technologies, Inc. Bolsters BolaWrap® 150 Deployments, Promoting Safer Communities Nationwide
- Zoned Properties Inc. (ZDPY) - InvestorNewsBreaks - Zoned Properties Inc. (ZDPY) Expands Portfolio, Supports Growth of Cannabis Industry with Acquisition of Arizona Property
The QualityStocks DailyNetwork Sponsors
About The QualityStocks Daily
The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.
Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.
"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.
The QualityStocks Numbers Report
QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.
The QualityStocks Sponsored News
- 180 Life Sciences Corp. (NASDAQ: ATNF) - InvestorNewsBreaks - 180 Life Sciences Corp. (NASDAQ: ATNF) Granted Extension to Regain Compliance with Nasdaq Listing Requirements
- Aditxt Inc. (NASDAQ: ADTX) - InvestorNewsBreaks - Aditxt Inc.'s (NASDAQ: ADTX) Merger Target Expects 'Fourth Consecutive Year of Net Sales Growth'
- Advanced Gold Exploration Inc. (CSE: AUEX) (FSE: 4TG) (OTC: AUHIF) - InvestorNewsBreaks - Advanced Gold Exploration Inc. (CSE: AUEX) Management to Attend Upcoming Global Mining Investment Conference
- Amesite Inc. (NASDAQ: AMST) - InvestorNewsBreaks - Amesite Inc. (NASDAQ: AMST) Announces Beta Enrollment for New App Designed to Enhance Personal Safety, Security
- Appia Rare Earths & Uranium Corp. (CSE: API) (OTCQX: APAAF) - InvestorNewsBreaks - Appia Rare Earths & Uranium Corp. (CSE: API) (OTCQX: APAAF) (FSE: A0I0) (MUN: A0I0) (BER: A0I0) Begins Drilling at Uranium-Bearing Loranger Property
- Fresh2 Group Ltd. (NASDAQ: FRES) - Appointment of New Independent Director
- Astiva Health - InvestorNewsBreaks – Astiva Health Providing Tailored Approach to Healthcare
- Arizona Metals Corp. (TSX: AMC) (OTCQX: AZMCF) - Copper Producers Start Paying Attention to 'Urban Mining'
- Astrotech Corp. (NASDAQ: ASTC) - TechMediaBreaks - Astrotech Corporation (NASDAQ: ASTC) Sets New Standard for Accuracy, Reliability in Narcotics Detection
- Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) - Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) Outlines Plans for Fully Funded Exploration Program at Epworth Project
- Augmedix Inc. (NASDAQ: AUGX) - Augmedix Partners with Google Cloud to Bring Medically-Tuned AI Technology to Ambient Documentation
- Battery Mineral Resources Corp. (TSX.V: BMR) (OTCQB: BTRMF) - InvestorNewsBreaks - Battery Mineral Resources Corp. (TSX.V: BMR) (OTCQB: BTRMF) Subsidiary Closes on Second Drawdown of Credit Facility
- Bebuzee Inc. (OTC: BBUZ) - TechMediaBreaks - Bebuzee Inc. (BBUZ) Bringing Future of Digital Engagement Through Game-Changing Super App
- BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) - InvestorNewsBreaks - BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Releases Shareholder Update with Corporate, Operational Highlights
- Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) - InvestorNewsBreaks - Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Releases Successful Preclinical Results In-Vivo Proof-of-Concept Psoriatic Human Skin Model Study
- Bravo Multinational Inc. (OTC: BRVO) - TechMediaBreaks - Bravo Multinational Inc. (BRVO) Tapping into Growth Projected Within Various Segments of the Streaming Market
- BioNxt Solutions Inc. (CSE: BNXT) (OTCQB: BNXTF) (FSE: 4XT) - InvestorNewsBreaks - BioNxt Solutions Inc. (CSE: BNXT) (OTCQB: BNXTF) (FSE: BXT) Announces Highly Promising Results from ODF Cladribine PK Study
- Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) - InvestorNewsBreaks - Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Collaborates to Open Gold Circulation Channels
- Btab Ecommerce Group Inc. (OTC: BBTT) - InvestorNewsBreaks - Btab Ecommerce Group Inc. (BBTT) to Strengthen Global Support for Small Businesses via Business Combination Agreement
- Canada Nickel Company Inc. (TSX.V: CNC) (OTCQX: CNIKF) - InvestorNewsBreaks - Canada Nickel Company Inc. (TSX.V: CNC) (OTCQX: CNIKF) Announces Creation of 'ExploreCo' to Unlock Value from Significant Asset Portfolio
- Cepton Inc. (NASDAQ: CPTN) - InvestorNewsBreaks - Cepton Inc. (NASDAQ: CPTN) Releases Q1 2024 Financial Report, Business Update
- CISO Global, Inc. (NASDAQ: CISO) - InvestorNewsBreaks - CISO Global Inc. (NASDAQ: CISO) Partners with Fortegra to Offer Protection Plans for Cybersecurity Clients
- Clene Inc. (NASDAQ: CLNN) - InvestorNewsBreaks - Clene Inc. (NASDAQ: CLNN) Management Slated to Participate in Upcoming Emerging Growth Conference
- CNS Pharmaceuticals Inc. (NASDAQ: CNSP) - InvestorNewsBreaks - CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Exec to Present at Upcoming Virtual Investor Closing Bell Series
- Correlate Energy Corp. (OTCQB: CIPI) - New UK Government Cancels Onshore Wind Farms Ban
- Coyuchi Inc. - Investment Advisor Warns That Politicizing ESG Isn’t Sustainable
- Cub Crafters Inc. - InvestorNewsBreaks – CubCrafters Inc. CEO Eyes Bright Future for Fleet Sales Program
- Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) - InvestorNewsBreaks - Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Sees "Swell" of Insider Investments, Upgrade in Ranking after Positive Year-End Report
- DarioHealth Corp. (NASDAQ: DRIO) - InvestorNewsBreaks - DarioHealth Corp. (NASDAQ: DRIO) Collaborates to Expand GLP-1 Solution
- Diamond Lake Minerals Inc. (OTC: DLMI) - InvestorNewsBreaks - Diamond Lake Minerals Inc. (DLMI) Enters Million-Dollar Share Exchange Agreement with Horizon Fintex
- Data443 Risk Mitigation Inc. (OTC: ATDS) - InvestorNewsBreaks - Data443 Risk Mitigation Inc. (ATDS) to Provide Updated Open-Source Offering, Threat-Intelligence Data to SORBS Community
- D-Wave Quantum Inc. (NYSE: QBTS) - Samsung Anticipates Profit Jump After Incorporating AI
- Electronic Servitor Publication Network Inc. (OTCQB: XESP) - Electronic Servitor Publication Network Inc. (XESP) Combines Powerful Digital Engagement Engine(TM) with Simple Pricing Model to Drive Growth of Client Companies
- ECGI Holdings Inc. (OTC: ECGI) - ECGI Holdings Inc. (ECGI) Aligning Operations to Target Faster and Consistent Growth Trajectory Down Proven Path
- Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) - Unconventional Market Factors Cause Gold Market to Rise
- Emperor Metals Inc. (CSE: AUOZ) (FRA:9NH) (OTCQB: EMAUF) - InvestorNewsBreaks - Emperor Metals Inc. (CSE: AUOZ) (OTCQB: EMAUF) (FRA: 9NH) Reports on Plans to Explore Eastern Extent at Duquesne West Gold Project
- Energy and Water Development Corp. (OTCQB: EAWD) - Energy and Water Development Corp. (EAWD) Offers an Off-grid Solution to Combat Clean Water Access Challenges Brought About by Climate Change
- Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) - InvestorNewsBreaks - Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Announces Strategic Appointment of Former Critical Minerals Leader from General Motors
- EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) - InvestorNewsBreaks - EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF) Signs 20-Year RNG Offtake Agreement with FortisBC, Secures Feedstock Supply Agreement
- Exro Technologies Inc. (TSX: EXRO) (OTCQB: EXROF) - InvestorNewsBreaks - Exro Technologies Inc.'s (TSX: EXRO) (OTCQB: EXROF) Reports on Shareholder Voting Held During 2024 Annual General Meeting
- FingerMotion Inc. (NASDAQ: FNGR) - How DePINS Could Disrupt the Global Telecoms Industry
- Fintech Ecosystem Development Corp. (NASDAQ: FEXD) - InvestorNewsBreaks - Fintech Ecosystem Development Corp. (NASDAQ: FEXD) Carving out Share in Challenger Bank, Crypto Markets
- First Tellurium Corp. (CSE: FTEL) (OTCQB: FSTTF) - Concerns Grow Regarding Market Consolidation as Moody's Exits ESG Ratings Segment
- Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) - InvestorNewsBreaks - Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) Releases Core Review Report on 'Blue Sky' Potential at Mal Lake
- FE Battery Metals Corp. (CSE: FE) (OTCQB: FEMFF) - InvestorNewsBreaks - FE Battery Metals Corp. (CSE: FE) (OTC: FEMFF) Report Positive Lab Results from Augustus Lithium Project Testwork
- Flora Growth Corp. (NASDAQ: FLGC) - InvestorNewsBreaks - Flora Growth Corp. (NASDAQ: FLGC) Announces Acquisition of Australian Vaporizers
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) - InvestorNewsBreaks - Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Partners with BuilderX Robotics for POC Project
- Freight Technologies Inc. (NASDAQ: FRGT) - InvestorNewsBreaks - Freight Technologies Inc. (NASDAQ: FRGT) Unveils Revolutionary State-of-the-Art Platform for Digital Ocean-Freight Booking, Management
- GEMXX Corp. (OTC: GEMZ) - GEMXX Corp. (GEMZ) Plans to Fully Harness Potential of Two Promising Target Basins in Latin America, Bolstered by Recent Strategic Addition to Primary Investment Target's Board
- FuelPositive Corp. (TSX.V: NHHH) (OTC: NHHHF) - Can Green Energy Replicate Sense of Culture, Community That Coal Mining Nurtured?
- GeoSolar Technologies Inc. - QualityStocksNewsBreaks – GeoSolar Technologies Inc. Taking Part in Shift Toward a Greener Future
- GivBux Inc. (OTC: GBUX) - InvestorNewsBreaks - GivBux Inc. (GBUX) Moves to Qualify as OTCQB Corporation
- Golden Matrix Group Inc. (NASDAQ: GMGI) - InvestorNewsBreaks - Golden Matrix Group Inc.'s (NASDAQ: GMGI) Releases Q2 Financial Report, Reports Record Revenue
- Golden Triangle Ventures Inc. (OTC: GTVH) - Golden Triangle Ventures Inc. (GTVH), Lavish Entertainment Report on Progress of One-of-a-Kind Entertainment Destination
- GolfLync Inc. - InvestorNewsBreaks - GolfLync Inc. Reaches 100K Membership Milestone, Sees 3,033% Growth Rate in 2023
- Genprex Inc. (NASDAQ: GNPX) - InvestorNewsBreaks - Genprex Inc. (NASDAQ: GNPX) Announces Participation at Upcoming Investor, Industry Events
- RYVYL Inc. (NASDAQ: RVYL) - InvestorNewsBreaks - RYVYL Inc. (NASDAQ: RVYL) Announces Agreement to Extend Repayment Date on Convertible Note
- HeartBeam Inc. (NASDAQ: BEAT) - InvestorNewsBreaks - HeartBeam Inc. (NASDAQ: BEAT) Now Listed on Russell Microcap Index
- HealthLynked Corp. (OTCQB: HLYK) - InvestorNewsBreaks - HealthLynked Corp. (HLYK) Announces New COO, Appoints Seasoned Veteran to Enhance Operations and Drive Initiatives
- Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTD) (FRA: 7HIA.F) - InvestorNewsBreaks - Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTF) (FSE: 7HI) Launches Prototype to Showcase ZVS Tech
- Horizon Fintex | Upstream - JP Morgan’s Onyx Mulls Leveraging Web3 for Social Commerce
- iClick Interactive Asia Group Ltd. (NASDAQ: ICLK) - InvestorNewsBreaks - iClick Interactive Asia Group Limited (NASDAQ: ICLK) Names New Board Member, Audit Committee Chair
- Ideanomics Inc. (NASDAQ: IDEX) - InvestorNewsBreaks - Ideanomics Inc. (NASDAQ: IDEX) Releases Financial Report for Q4, FY 2023
- IGC Pharma Inc. (NYSE American: IGC) - InvestorNewsBreaks - IGC Pharma Inc.'s (NYSE American: IGC) TGR-63 Demonstrates Blood-Brain Barrier Permeability in Preliminary Findings
- Infobird Co., Ltd (NASDAQ: IFBD) - InvestorNewsBreaks - Infobird Co. Ltd. (NASDAQ: IFBD) Announces Delayed Effective Date of Reverse Split
- InMed Pharmaceuticals Inc. (NASDAQ: INM) - BioMedNewsBreaks - InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Significant Improvements from INM-089 in AMD, Validates INM-901 as Potential AD Treatment
- Safety Shot Inc. (NASDAQ: SHOT) - InvestorNewsBreaks - Safety Shot (NASDAQ: SHOT) Cuts Ties with Brand Ambassador, Reinforces 'Zero Tolerance' for Discrimination and Hate Speech
- BlockQuarry Corp. (OTC: BLQC) - InvestorNewsBreaks - BlockQuarry Corp (BLQC) Looking Toward Future with Pivotal Shift to AI-Driven Data Storage, High-Performance Computing
- Knightscope (NASDAQ: KSCP) - InvestorNewsBreaks - Knightscope, Inc. (NASDAQ: KSCP) Launches New K1 Laser Solution for Physical Security
- Laredo Oil Inc. (OTC: LRDC) - InvestorNewsBreaks - Laredo Oil Inc. (LRDC) Subisidary Begins Drilling on Well in Montana-Based Midfork Location
- Longeveron Inc. (NASDAQ: LGVN) - InvestorNewsBreaks - Longeveron Inc.'s (NASDAQ: LGVN) Lomecel-B(TM) Granted RMAT Designation for the Treatment of Mild Alzheimer's Disease
- Lexaria Bioscience Corp. (NASDAQ: LEXX) - InvestorNewsBreaks - Lexaria Bioscience Corp. (NASDAQ: LEXX) Makes Management Announcement, Plans for Strategic Growth
- Life Electric Vehicles Holdings Inc. (OTC: LFEV) - InvestorNewsBreaks - Life Electric Vehicles Holdings Inc. (LFEV) Engages IBN for Corporate Communications Expertise
- Lottery.com Inc. (NASDAQ: LTRY) - InvestorNewsBreaks - Lottery.com Inc. (NASDAQ: LTRY) Enters Agreement with New Strategic Financial Adviser
- LQwD Technologies Corp. (TSX.V: LQWD) (OTCQB: LQWDF) - InvestorNewsBreaks - LQWD Technologies Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Reports on Status of Bitcoin Lightning Network Operations
- Lucy Scientific Discovery Inc. (NASDAQ: LSDI) - Neuroscience Study Shows Psychedelic-Assisted Therapy Causes Rapid Changes in Brain
- McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) - MiningNewsBreaks - McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Positioned as Standout Opportunity for Investors
- MetAlert Inc. (OTC: MLRT) - Researchers Find Balancing Ability May Predict Risk of Cognitive Decline
- Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) - MIND CURE HEALTH INC. ANNOUNCES CLOSING OF THE FIRST TRANCHE OF LNG ENERGY GROUP'S SUBSCRIPTION RECEIPT FINANCING
- Mydecine Innovations Group Inc. (NEO: MYCO) (FSE: 0NFA) (OTC: MYCOF) - InvestorNewsBreaks - Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Board Approves Issuance of Shares for Debt Settlement
- Nemaura Medical Inc. (NASDAQ: NMRD) - InvestorNewsBreaks - Nemaura Medical Inc. (NASDAQ: NMRD) Announces Positive Nasdaq Listing Decision
- NextPlat Corp. (NASDAQ: NXPL) (NASDAQ: NXPLW) - Web3 Users Surge 40% in Q2, Reach Historic High
- Nightfood Holdings Inc. (OTCQB: NGTF) - Service on the Rise: How Automation and Nightfood Holdings Inc. (NGTF) are Redefining Hospitality
- Nowigence Inc. (OTCQB: NOWG) - Nowigence Inc. (NOWG) Starts Trading on OTC
- Nutriband Inc. (NASDAQ: NTRB) - InvestorNewsBreaks - Nutriband Inc. (NASDAQ: NTRB) Obtains Notice of Allowance for Key Trademark Identified as 'Integral' to Platform Technology
- OK Stone Engineering Inc. - InvestorNewsBreaks — OK Stone Engineering Partners with Oren Klaff at Special Investor Event
- Mullen Automotive Inc. (NASDAQ: MULN) - Mullen Announces POWER BOOST, Industry-First Solid-State Polymer Battery Pack Exchange Program
- PaxMedica Inc. (NASDAQ: PXMD) - BioMedNewsBreaks - PaxMedica Inc. (PXMD) Intensifying Efforts to Achieve Significant Program Milestones
- PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) - InvestorNewsBreaks - PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTC: PLTXF) Amends Proposed 1-to-35 Share Consolidation
- Playgon Games Inc. (TSX.V: DEAL) (OTC: PLGNF) - InvestorNewsBreaks - Playgon Games Inc. (TSX.V: DEAL) (OTC: PLGNF) (FSE: 7CR) Receives Recognition for 'Pushing the Boundaries of Live Dealer Gaming'
- PowerTap Hydrogen Capital Corp. (NEO: MOVE) (FWB: 2K6A) (OTC: MOTNF) - InvestorNewsBreaks - PowerTap Hydrogen Capital Corp. (NEO: MOVE) (OTC: MOTNF) Releases Biweekly Status Update
- Predictive Oncology (NASDAQ: POAI) - InvestorNewsBreaks - Predictive Oncology Inc. (NASDAQ: POAI) Unveils Novel Technology, Eyes Significant Partnership Opportunities
- Pressure BioSciences Inc. (PBIO) - InvestorNewsBreaks - Pressure BioSciences Inc. (PBIO), Vita-Forte Collaborate to Commercialize Highly Potent UST Nanoemulsion Oral Spray
- Processa Pharmaceuticals Inc. (NASDAQ: PCSA) - InvestorNewsBreaks - Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Positive Efficacy Results from Phase 1b Trial
- Progressive Care Inc. (OTCQB: RXMD) - InvestorNewsBreaks - Progressive Care Inc. (RXMD) Releases Q1 2024 Financial Report Showing Record Revenue
- Prospera Energy Inc. (TSX.V: PEI) (FRA: OF6B) (OTC: GXRFF) - InvestorNewsBreaks - Prospera Energy Inc. (TSX.V: PEI) (OTC: GXRFF) (FRA: OF6B) Has 550,000 Common Shares Acquired by Investor
- Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) - InvestorNewsBreaks - Red White & Bloom Brands Inc. (CSE: RWB) (OTC: RWBYF) Files Documents Reporting Financial Results for Q4, FY 2023
- Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF) - European Climate Survey Reports Older Adults Have Better Grasp of the Environment
- Reunion Gold Corp. (TSX.V: RGD) (OTCQX: RGDFF) - InvestorNewsBreaks - Reunion Gold (TSX.V: RGD) (OTCQX: RGDFF) Announces Completion of Business Combination with G Mining Ventures
- REZYFi, Inc. - InvestorNewsBreaks – REZYFi Inc. Using Diversified Approach to Capitalize on Growth in Multiple Verticals
- RJD Green Inc. (OTC: RJDG) - InvestorNewsBreaks - RJD Green Inc. (RJDG) Eyes Additional Revenue, Profit Opportunities Through Silex Holdings Division
- N2OFF Inc. (NASDAQ: NITO) - InvestorNewsBreaks - N2OFF Inc. (NASDAQ: NITO) Reports Reduction in N2O Emissions in Corn Cultivation
- Software Effective Solutions Corp. (OTC: SFWJ) - New Hemp Reference Material from NIST to Ensure Accuracy in Cannabis Measurement
- Sigyn Therapeutics Inc. (OTCQB: SIGY) - BioMedNewsBreaks - Sigyn Therapeutics Inc. (SIGY) Leveraging Portfolio to Overcome Current Limitations in Healthcare
- Silo Pharma Inc. (OTCQB: SILO) - InvestorNewsBreaks - Silo Pharma Inc. (NASDAQ: SILO) Announces Exclusive Global License to Develop, Manufacture, Commercialize Alzheimer Drug
- SUIC Worldwide Holdings Ltd. (OTC: SUIC) - SUIC Worldwide Holdings Ltd. (SUIC) Using Technology and Financing to Magnify Potential and Opportunities of Promising Businesses
- SuperCom Ltd. (NASDAQ: SPCB) - Wearable, Unobtrusive, High-performing Technology Gives SuperCom Ltd. (NASDAQ: SPCB) Key Advantages in EM Offender Tracking Market
- Siyata Mobile Inc. (NASDAQ: SYTA) - InvestorNewsBreaks - Siyata Mobile Inc. (NASDAQ: SYTA), Zello Partner to Integrate Top-Rated App and SD7 Handset
- SOBRsafe Inc. (NASDAQ: SOBR) - SOBRsafe Inc. (NASDAQ: SOBR) Secures Two New Agreements to Provide Its Next-Generation Transdermal Alcohol Detection Solutions to Customers in Behavioral Health Segment
- Splash Beverage Group Inc. (NYSE American: SBEV) - InvestorNewsBreaks - Splash Beverage Group Inc. (NYSE American: SBEV) Partners to Expand Footprint in Colorado
- Standard Lithium Ltd. (NYSE American: SLI) - InvestorNewsBreaks - Standard Lithium Ltd. (TSX.V: SLI) (NYSE American: SLI) (FRA: S5L), Announces Participation in June Industry Events
- Starco Brands Inc. (OTCQB: STCB) - Whipshots® by Starco Brands Shatters Expectations with Explosive Growth and Nationwide Expansion
- StorEn Technologies Inc. - InvestorNewsBreaks – StorEn Technologies Inc. Recognized for Bringing Real Innovation to Vanadium Flow Batteries
- Vision Marine Technologies Inc. (NASDAQ: VMAR) - InvestorNewsBreaks - Vision Marine Technologies Inc. (NASDAQ: VMAR) Announces Strategic Collaboration, Expansion in Growing Electric Boat Rental Market
- SenesTech Inc. (NASDAQ: SNES) - SenesTech Inc. (NASDAQ: SNES) Scores Major Client with Evolve(TM) Deployment in the U.S. Virgin Islands
- Sekur Private Data Ltd. (FRA: GDT0) (CSE: SKUR) (OTCQB: SWISF) - InvestorNewsBreaks - Sekur Private Data Ltd. (CSE: SKUR) (OTCQX: SWISF) (FSE: GDT0) Spotlighted in Most Recent "New to the Street" Episode
- TAAT Global Alternatives Inc. (CSE: TAAT) (FRANKFURT: 2TP) (OTCQX: TOBAF) - InvestorNewsBreaks - TAAT(TM) Global Alternatives Inc. (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2) Plans 10-to-One Share Consolidation
- Tartisan Nickel Corp. (CSE: TN) (OTCQB: TTSRF) - Tartisan Nickel Corp. (CSE: TN) (OTCQB: TTSRF) (FSE: 8TA) Targets Rapid Global Growth in Nickel Demand
- SOBRsafe Inc. (NASDAQ: SOBR) - SOBRsafe Inc. (NASDAQ: SOBR) Secures Two New Agreements to Provide Its Next-Generation Transdermal Alcohol Detection Solutions to Customers in Behavioral Health Segment
- TRxADE HEALTH, INC. (NASDAQ: MEDS) - InvestorNewsBreaks - TRxADE Health Inc. (NASDAQ: MEDS) Announces Special Cash Dividend
- Torr Metals Inc. (TSX.V: TMET) - Copper Crunch Looms: Torr Metals Inc. (TSX.V: TMET) Makes Discoveries as Demand Outpaces Supply
- Trillion Energy International Inc. (CSE: TCF) (OTCQB: TRLEF) - InvestorNewsBreaks - Trillion Energy International Inc. (CSE: TCF) (OTCQB: TRLEF) Issues Update on SASB Program
- Turbo Energy S.A. (NASDAQ: TURB) - InvestorNewsBreaks - Turbo Energy S.A. (NASDAQ: TURB) Shares Results of 2024 Annual General Meeting
- Uranium Energy Corp. (NYSE American: UEC) - InvestorNewsBreaks - Uranium Energy Corp. (NYSE American: UEC) Reconfirms Position as America's Leading ISR Uranium Company with New TRS Filing
- Vision Marine Technologies Inc. (NASDAQ: VMAR) - InvestorNewsBreaks - Vision Marine Technologies Inc. (NASDAQ: VMAR) Announces Strategic Collaboration, Expansion in Growing Electric Boat Rental Market
- VistaGen Therapeutics Inc. (NASDAQ: VTGN) - InvestorNewsBreaks - Vistagen Therapeutics Inc. (NASDAQ: VTGN) Awarded New Patents from Four Countries to Broaden Global PH80 IP Portfolio
- Vivos Therapeutics Inc. (NASDAQ: VVOS) - InvestorNewsBreaks - Vivos Therapeutics Inc. (NASDAQ: VVOS) Reports Results of Seven-Month Provider-Based Marketing and Distribution Model Pilot
- Wrap Technologies Inc. (NASDAQ: WRAP) - Wrap Technologies, Inc. Bolsters BolaWrap® 150 Deployments, Promoting Safer Communities Nationwide
- Zoned Properties Inc. (ZDPY) - InvestorNewsBreaks - Zoned Properties Inc. (ZDPY) Expands Portfolio, Supports Growth of Cannabis Industry with Acquisition of Arizona Property
The QualityStocks DailyNetwork Sponsors
About The QualityStocks Daily
The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.
Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.
"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.